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ABSTRACT 
COORDINATION OF PRIMER SUGAR SYNTHESIS 
WITH O-ANTIGEN INITIATION 
IN RHIZOBIUM ETLI CE3 
Tiezheng Li, B.S. 
Marquette University, 2014 
All organisms synthesize amidosugars, such as N-acetylglucosamine (GlcNAc), and 
deoxysugars, such as fucose. They are found in important polysaccharides and glycoconjugates 
such as glycoproteins. N-acetylquinovosamine (QuiNAc) is both an amido- and a deoxy-sugar. It 
is found in many examples of an important prokaryotic glycoconjugate, the lipopolysaccharide 
(LPS) that coats the surface of Gram-negative bacteria. Like N-glycosylation of glycoproteins, 
LPS has a portion that is synthesized first on a polyprenyl lipid carrier and then transferred to the 
rest of the molecule. 
 
QuiNAc is believed to initiate the O-antigen portion of LPS of Rhizobium etli CE3. 
Genetic studies identified three genes, wreV, wreU and wreQ, required for the initial steps of O-
antigen synthesis in R. etli CE3. Based on the predicted roles of the gene products and the theory 
of polysaccharide biosynthesis, there was a very straightforward prediction of the initial events: 
WreV catalyzes conversion of UDP-GlcNAc to its 4-keto-6-deoxy derivative, which WreQ 
reduces to UDP-QuiNAc, followed by transfer of QuiNAc-1-phosphate to the lipid carrier by 
WreU. However, the LPS structure of R. etli wreQ mutants was also consistent with a second, 
novel possibility. 
  
These two hypotheses were tested by developing assays in vitro for each of the predicted 
enzymes. Two key findings were 1) that WreU catalysis is 30-fold faster with the 4-keto 
intermediate as substrate than with UDP-QuiNAc, and 2) WreQ catalyzes the reduction the 4-keto 
sugar to QuiNAc orders of magnitude faster when it is linked to lipid rather than to UDP. 
 
The results strongly support the second hypothesis, outlined as follows: After 4,6-
dehydration of UDP-GlcNAc, the 4-keto-6-deoxysugar-1-phosphate moiety is transferred to the 
lipid carrier, thereby providing the sugar stem for the rest of O-antigen synthesis. Only then is the 
4-keto sugar reduced to QuiNAc. The order of enzyme reactions suggests an interesting chemical 
coordination between the initiation of the O antigen and QuiNAc synthesis. It also includes the 
unorthodox completion of deoxysugar synthesis on a lipid carrier. Because the presence of 
QuiNAc and WreQ homologs are highly correlated in bacterial species, this may be the normal 
mechanism by which QuiNAc becomes part of bacterial polysaccharides
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CHAPTER ONE: INTRODUCTION 
A. Lipopolysaccharide (LPS) 
The surface of Gram-negative bacteria consists of two membrane bilayers sandwiching a 
thin peptidoglycan (PGN) layer and the periplasm (Fig. 1). The outer leaflet of the outer-
membrane bilayer is mainly composed of lipopolysaccharides (LPS). The LPS molecule typically 
consists of three structural regions (Fig. 1): a hydrophobic lipid A, a non-repeating core 
oligosaccharide, and a distal polysaccharide called O antigen. Lipid A comprises the outer 
monolayer of the outer membrane and anchors the sugar moieties. The structure of lipid A is 
highly conserved among species (1). The core region extends outward from lipid A and provides 
an attachment site for the O antigen. O antigen is the most surface-exposed portion of LPS. The 
extent of structural variation in core oligosaccharides is limited within a given species, or even a 
genus. In contrast, the structure of O antigens varies from strain to strain in the same species (2).  
 
B. The LPS of Rhizobium etli CE3 
Rhizobium etli CE3, as a member of the α-proteobacteria, has the canonical Gram-
negative cell surface. The structures of all three portions of R. etli CE3 LPS have been determined 
(3-5). It is one of the best known LPSs, both structurally and functionally.  
Like in many other Gram-negative bacteria, two forms of LPS exist in R. etli CE3: the 
smooth LPS (or LPS I) and the rough LPS (or LPS II). LPS I contains all three structural regions 
of an LPS while LPS II contains only lipid A and core, lacking the O antigen. The two forms of 
LPS can be separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) 
and visualized by silver staining (6) (Fig. 2). Mutants deficient in O-antigen biosynthesis can be 
identified by their altered LPS banding pattern. Those lacking O antigen completely have no 
visible LPS I bands, and the amount of LPS II per cell is increased (Fig. 2).  
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Figure 1. Schematic representation of the surface of gram-negative bacteria. 
Lipopolysaccharides (LPS) comprise the outer monolayer of the outer membrane. The three 
domains of LPS, lipid A, core oligosaccharide and O antigen, are shown. The inner monolayer of 
the outer membrane and the inner membrane bilayer are composed of phospholipids. A thin 
peptidoglycan layer is located in the periplasm between the two membrane bilayers. 
 
Figure 2. Separation of R. etli LPS I and LPS II. A silver-stained SDS-PAGE gel (18%) with 
LPS samples from whole-cell lysates. Left lane, the R. etli wildtype strain CE3 makes two forms 
of LPS, one with O-antigen (LPS I), one without (LPS II); Right Lane, an O-antigen mutant (Oag-) 
strain lacks LPS I, and has more abundant LPS II. This specific Oag- mutant is defective in the 
wreU gene. 
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C. The biological role of O antigen and the specific role of R. etli CE3 O antigen 
The location of O antigen at the cell surface places it at the interface between the 
bacterium and its surrounding environment. Early interest in the study of O-antigen structure and 
biosynthesis was stimulated by their roles as essential virulence determinants and their potential 
application in vaccine development. But now, information is available for a wide range of species 
with different lifestyles (2). The primary role of the O antigen appears to be protective. Animal 
pathogens use O antigen to evade host immune responses, particularly the complement system. 
The assembly of the membrane attack complex is affected by features of O antigen such chain 
length and relative amount of long-chain LPS (7,8).  
In Rhizobium-plant symbiosis, the O antigen may confer resistance to plant defense 
mechanisms (9) and may serve as signals that trigger the plant to allow the infection to proceed. 
The O antigens of Rhizobium species are essential in the infection of their host legumes to form 
nitrogen-fixing root nodules (6,10,11). Mutants derived from R. etli CE3 that do not make O 
antigen, make truncated O antigens, or make normal-length O antigen in reduced amount, are 
deficient in symbiosis (6). The O-antigen mutants were still able to initiate the nodulation process 
but nodules elicited by them were undeveloped, bacteria-free and unable to fix nitrogen (6). 
 
D. Structure of the R. etli CE3 O antigen 
The O antigen of R. etli CE3 is a fixed-length heteropolymer (4). Its structure has been 
defined in four parts: the primer, adapter region, repeating units and a terminal residue (Fig. 3) 
(12). The identity of the first sugar residue of O antigen, as depicted in Fig. 3, is a hypothesis. 
Only with the biosynthetic analysis reported in this dissertation is this hypothesis now being 
confirmed. However, strong arguments based on comparison to other O-antigen structures and 
evidence from previous genetic studies, suggested that the primer sugar is QuiNAc (2-acetamido-
2,6-dideoxy-D-glucose or N-acetyl-D-quinovosamine) (12). The adapter region refers to sugars 
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added after the primer and before the repeating units, and it is composed of a mannose (Man) and 
then a fucose (Fuc) in R. etli CE3. The repeating unit of R. etli CE3 is a branched trisaccharide 
composed of a Fuc, a glucuronic acid methyl ester (MeGlcA) and a 3-O-methyl-6-deoxytalose 
(3OMe6dTal). After this unit is repeated five times the O antigen ends in either a 2,3-di-O-
methylated or 2,3,4-tri-O-methylated fucose (4). 
 
Figure 3. Structure of Rhizobium etli CE3 O antigen. The full O-antigen structure is shown 
linked to the lipid A-core, the structure of which are not shown in detail. The primer, adapter 
region, repeating units and terminal residue are indicated. The first sugar residue of the O antigen, 
as depicted here, is a hypothesis. Abbreviations for the sugars: QuiNAc, N-acetyl-D-
quinovosamine; Man, mannose; Fuc, fucose; MeGlcA, glucuronyl methyl ester; 3OMe6dTal, 3-
O-methyl-6-deoxytalose; Terminal residue, TOMFuc, 2,3,4-tri-O-methylfucose or DOMFuc, 2,3-
di-O-methylfucose. 
E. O-antigen biosynthesis 
The O-antigen portion of LPS is not synthesized directly on the core oligosaccharide. 
Instead, it is assembled on a lipid carrier molecule, termed undecaprenyl phosphate (Und-P). This 
is the same C55-isoprenoid alcohol derivative used for the synthesis of peptidoglycan (13) and 
most exopolysaccharides (14). During the synthesis phase, the growing polysaccharides are 
linked at the reducing end to undecaprenyl pyrophosphate (Und-PP) (Fig. 4). Fig. 5 outlines the 
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overall postulated scheme by which the CE3 O antigen is synthesized on the cytoplasmic face of 
the inner membrane, exported to the periplasmic face, transferred from Und-PP to lipid A-core, 
and then translocated to the outer membrane. Despite the accumulated information of hundreds of 
O-antigen structures and hundreds of biosynthesis gene clusters, there are relatively few detailed 
biochemical investigations of O-antigen synthesis and the synthetic process remains poorly 
defined. Many of the individual enzymatic mechanisms are speculative, and even functions based 
on sequence similarities are tenuous. 
 
Figure 4. O antigens are assembled on the lipid carrier undecaprenyl phosphate on the 
cytoplasmic face of the inner membrane. Shown here is the O antigen of R. etli CE3 as it 
putatively would appear at the end of its biosynthesis before transport to the periplasmic face of 
the inner membrane. inset, undecaprenyl phosphate (Und-P). 
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Figure 5. The overall scheme of O-antigen and LPS biosynthesis expected to occur in R. etli 
CE3. The O antigen of R .etli CE3 is believed to be synthesized by the ABC-transporter-
dependent pathway due to the presence of ABC-transporter genes in its O-antigen cluster (15) and 
was supported by genetic studies (16). In this pathway, the entire O antigen is assembled on the 
cytoplasmic face of the inner membrane. The first step is catalyzed by an initiating 
glycosyltransferase (GTase), which transfers the sugar-1-phosphate moiety from a UDP-sugar 
donor to the lipid carrier undecaprenyl phosphate (step #1). Chain extension occurs at the 
nonreducing end by transferring the rest of the O-antigen sugars one after another until 
completion (step #2). Once completed, the lipid-linked O-antigen intermediate is transported by 
an ABC transporter to the periplasmic face of the inner membrane (step #3). There, O antigen is 
ligated to the lipid A and core regions (step #4). Finally, the completed LPS is mobilized to the 
outer membrane (step #5). The focus of this dissertation is on the initial steps. The purpose of this 
figure is to put these steps into the context of the overall process. In this figure, no attempt is 
made to depict the biosynthetic enzymes or their possible interactions with each other and the 
ABC transporter. The other major pathway, Wzy-dependent, differs from this pathway in that 
each repeating unit is synthesized on a lipid carrier on the cytoplasmic face and transported to the 
periplamic face of the inner membrane individually. There they are polymerized in a way that 
chain extension is at the reducing end, like peptidoglycan. 
F. Genetic studies of R. etli CE3 O-antigen biosynthesis 
In general, O-antigen synthesis genes are found in clusters (2,17). Those in R. etli CE3 
are no exception. Nearly all genes required to synthesize the known R. etli CE3 O-antigen 
structure are located on the chromosome, spanning nucleotides 784,527 to 812,262 (Fig. 6A) (15) 
(previously designated the lps α region (18)). This gene cluster includes genes encoding eight 
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putative glycosyltransferases (GTases), the ABC-transporter proteins, enzymes for sugar 
synthesis or modification and several genes with unknown function (12). In addition to this 
cluster, genes required for O-antigen biosynthesis have been identified elsewhere on the 
chromosome (Fig. 6B) (19) and on plasmid pCFN42b (Fig. 6C) (20). Except for well-known 
orthologous genes, genes involved in O-antigen biosynthesis in R. etli have been given the 
designation wre (“w” stands for O-antigen genes, “re” stands for R. etli) (21), in order to conform 
with the conventions of naming O-antigen-related genes (22). 
The functions of most of the genes have been assigned based mainly on mutagenesis 
studies and sequence homology of the encoded proteins to well-characterized enzymes. For 
example, each putative GTase gene has been studied individually by mutagenesis and their 
predicted functions can account for each step of O-antigen biosynthesis (12). The availability of 
complete O-antigen structure and genetic information make R. etli CE3 one of the best candidates 
for detailed biochemical investigations of heteropolymeric O-antigen biosynthesis. Gene wreU, 
wreV and wreQ will be the focus of this dissertation and proved to be responsible for the 
synthesis and attachment of the first O-antigen sugar, QuiNAc. Interestingly, all of them are 
located outside the 28-kb O-antigen genetic cluster. 
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Figure 6. R. etli CE3 O-antigen genetic clusters. (A) A 28-kilobase cluster (previously called lps region α) on the chromosome, spanning 
nucleotides 784,527 to 812,262 of the genome sequence and consisting of 25 predicted ORFs. (B) A single ORF spanning nucleotides 2,969,313 
to 2,970,242 on the chromosome, that has been previously identified as being required for O-antigen synthesis (19). (C) A 4-kilobase cluster on 
plasmid pCFN42b consisting of three predicted ORFs. The genes specifically studied in this dissertation, wreG, wreQ, wreU and wreV, are shown 
with enlarged arrows, with name on top. Nucleotide numbering indicates the start and stop of each of the four genes and the edge of each genetic 
cluster.
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G. The initial step of O-antigen biosynthesis 
To the extent studied previously, all O-antigen biosyntheses have similar initiation 
reactions (2). An initiating GTase catalyzes the formation of an Und-PP-linked glycose by 
transfer of a sugar-1-phosphate (sugar-1-P) residue to Und-P. This enzyme differs from other O-
antigen GTases in two aspects (Fig. 7): first, it recognizes a hydrophobic lipid carrier rather than 
the sugar acceptor used by the other GTases; second, it transfers the sugar-1-P of a nucleotide 
diphosphate (NDP) sugar donor whereas other GTases only transfer the sugar. 
 
Figure 7. Comparing the reactions catalyzed by the initiating GTase and other GTases in O-
antigen biosynthesis. (A) All characterized initiating GTases are integral membrane proteins. 
They catalyze the transfer of sugar-1-phosphate from a UDP-sugar donor to the lipid carrier Und-
P. (B) Most other GTases involved in O-antigen synthesis are not predicted to have 
transmembrane segments. They transfer only the sugar moiety from an NDP-sugar donor to 
another sugar acceptor. 
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Biochemical characterizations of the initiating GTases are relatively limited, mainly due 
to problems encountered with their overexpression and purification. The best characterized ones 
are WecA from E. coli (formerly Rfe) (23) and WbaP from Salmonella enterica (formerly RfbP) 
(24).  
E. coli WecA is an integral membrane protein with 11 transmembrane (TM) segments 
(Fig. 8A) (25). Recently, the WecA protein from the thermophilic bacterium Thermotoga 
maritima was successfully purified and shown to catalyze the transfer of GlcNAc-1-P moiety 
from UDP-GlcNAc onto the lipid carrier Und-P (26). 
WbaP initiates O-antigen synthesis in Salmonella enterica by catalyzing the transfer of 
galactose-1-P onto Und-P. The WbaP protein possesses three predicted domains: an N-terminal 
region containing four predicted transmembrane segments, a large central periplasmic loop and a 
C-terminal domain containing the last transmembrane segment and a large cytoplasmic tale (Fig. 
8B) (27,28). The C-terminal domain alone is sufficient for the GTase activity of WbaP; the 
truncated protein (WbaP250-476) could complement the synthesis of O antigen in a S. enterica 
ΔwbaP::cat mutant strain (27). Recently, a truncated WbaP containing the C-terminal domain 
(WbaP258-476) was purified with a removable N-terminal thioredoxin fusion and shown to possess 
GTase activity in vitro (29). 
 
H. The initial step of O-antigen biosynthesis in R. etli CE3 
The initiating GTase—There is strong, albeit indirect, evidence that the gene wreU 
encodes the initiating GTase for R. etli CE3 O-antigen biosynthesis. The argument is based on 
sequence homology, wreU gene mutagenesis, and chemical analysis of the LPS produced by the 
wreU mutant (12). The WreU protein is predicted to possess a single TM segment at its N-
terminus, followed by a large cytoplasmic tail (Fig. 8C). Sequence alignment showed that WreU 
is homologous to the C-terminal domain of WbaP (Fig. 9). 
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Figure 8. Topological models of initiating GTases. The shaded rectangular boxes represent 
transmembrane (TM) segments. The numbers indicate the amino acid positions of the boundary 
of each TM segment. (A) Escherichia coli WecA; (B) Salmonella enterica WbaP; (C) Rhizobium 
etli WreU. 
The first sugar of O antigen—As mentioned above, the first sugar (primer) of the R. etli 
CE3 O antigen was predicted to be QuiNAc. This prediction was based on comparison to other 
O-antigen structures and was supported by genetics studies (12). LPS sugar composition analysis 
of many O-antigen mutants showed that they each had significantly less QuiNAc than galactose, 
a core-specific sugar, suggesting that QuiNAc is not synthesized as part of the core region (12). 
Studies of R. etli CE3 LPS showed that QuiNAc is linked to the non-reducing end of a Kdo (3-
deoxy-D-manno-oct-2-ulosonic acid) residue (4,31). Biosynthetic/genetic studies strongly 
supported that this Kdo is part of the biosynthetic core of the LPS (5,32-34). 
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WreU      ---MGLKRAVDFLLALIASVILLVPILVVALSVRLTSPGPILYWSKRIGRFNQIFLMPKF 57 
WbaP      RSSRFLKRTFDIVCS-IMILIIASPLMIYLWYKVTRDGGPAIYGHQRVGRHGKLFPCYKF 332 
               ***:.*:: : *  :*:  *:::        . ** :*  :*:**. ::*   ** 
 
WreU      RSMRVDTPTVATHLLEN---------------PERFLTPIGSFLRKSSLDELPQLWCILA 102 
WbaP      RSMVMNSQEVLKELLANDPIARAEWEKDFKLKNDPRITAVGRFIRKTSLDELPQLFNVLK 392 
          *** :::  * ..** *                :  :* :* *:**:********: :*  
 
WreU      GKMSFVGPRPALYNQYDLIELRTVYGVDKLLPGLTGWAQINGRDELPIPEKVKFDVEYLE 162 
WbaP      GDMSLVGPRPIVSDELERYCDDVDY-YLMAKPGMTGLWQVSGRNDVDYDTRVYFDSWYVK 451 
          *.**:***** : :: :     . *      **:**  *:.**:::    :* **  *:: 
 
WreU      RRSLGFDMRILFLTAEKVVRRKGIKH 188 
WbaP      NWTLWNDIAILFKTAKVVLRRDGAY- 476 
          . :*  *: *** **: *:**.*    
Figure 9. Alignment of the predicted WreU amino acid sequence with the C-terminal 
domain of WbaP (amino acids 274-476) by use of the Clustal Omega program (30). 
The initiating reaction—Based on these independent evidence, the simplest hypothesis is 
that WreU transfers the QuiNAc-1-P to the lipid carrier Und-P to form undecaprenyl-
pyrophosphate-linked QuiNAc (Und-PP-QuiNAc), the first intermediate in O-antigen 
biosynthesis. 
However, these inferences above remain to be verified experimentally in vitro. In 
particular, no enzyme has been directly demonstrated to be an initiating GTase that transfers 
QuiNAc-1-P. One obstacle to such studies is that the expected biosynthetic donor of the QuiNAc 
residue, UDP-QuiNAc, has never been chemically synthesized in vitro. 
 
I. The proposed two-step biosynthetic pathway for UDP-QuiNAc 
The proposed biosynthetic pathway of UDP-QuiNAc in R. etli CE3 involves two steps 
(19,35) (Fig. 10). In the first step, the precursor UDP-GlcNAc is converted by a 4,6-dehydratase 
to its 4-keto-6-deoxy derivative, UDP-2-acetamido-2,6-dideoxy-D-xylo-4-hexulose (UDP-
ADHexu). In the second step, UDP-ADHexu is further converted to UDP-QuiNAc by a 4-
reductase.  
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Figure 10. The suggested biosynthetic pathway for the synthesis of UDP-QuiNAc. Enzymes 
that has been demonstrated biochemically (such as Pa WbpM, Cj PglF and Ye WbcP) or has been 
proposed (such as Re WreV, Re WreQ and Pa WbpV) to catalyze each reaction are listed in 
rectangle boxes. Pa, Pseudomonas aeruginosa; Cj, Campylobacter jejuni; Ye, Yersinia 
enterocolitica; Re, Rhizobium etli. 
The first step is shared in the biosynthetic pathways of many UDP-6-deoxy-sugars 
derived from UDP-GlcNAc (36) and this step has been reproduced in vitro by use of several 
homologous enzymes, including WbpM from Pseudomonas aeruginosa (37), PglF (Cj1120c) 
from Campylobacter jejuni (38,39) and WbcP from Yersinia enterocolitica (40). All these 
proteins are integral transmembrane proteins and they belong to a group of long-chain 
dehydratases characterized by the NAD-binding domains (GXXGXXG) and the SMK catalytic 
triad (41). The wreV gene of R. etli CE3 encodes a protein that is highly homologous to WbpM 
(Fig. 11A). Thus, WreV may catalyze the conversion of UDP-GlcNAc to UDP-ADHexu in R. etli 
CE3. 
In contrast, the second-step reaction and an enzyme responsible it have never been 
demonstrated in vitro. The wreQ gene of R. etli CE3 has been proposed to encode the 4-reductase 
for the second-step of UDP-QuiNAc synthesis (19). The predicted amino acid sequence suggests 
that WreQ belongs to the short chain dehydratase/reductase (SDR) superfamily, characterized by 
the GXXGXXG nucleotide-binding motif and the SYK catalytic triad (19,42).  
WreQ is homologous to the predicted protein sequence encoded by the wbpV gene of P. 
aeruginosa serotype O6 (Fig. 11B). wbpV gene and the aforementioned wbpM gene encoding the 
4,6-dehydratase are both located in a cluster of genes involved in B-band O-antigen synthesis in P. 
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aeruginosa O6. They have have been independently proposed to catalyze UDP-QuiNAc synthesis 
(43). 
 
A 
 
WreV      -----------MPRAAKRALALLVDSGLCVLTIWLAYCFRLNEWT---VLTGVQWLPVFV 46 
WbpM      MLDNLRIKLLGLPRRYKRMLQVAADVTLVWLSLWLAFLVRLGTEDMISPFSGHAWLFIAA 60 
                     :**  ** * : .*  *  *::***: .**        ::*  ** : . 
 
WreV      SLCMALPIFIVMGMYRAIFRYANMAAFIAVLKAIAIYGVAFMTIFT--ALSVPGVPRTVG 104 
WbpM      -PLVAIPLFIRFGMYRAVMRYLGNDALIAIAKAVTISALVLSLLVYWYRSPPAVVPRSLV 119 
             :*:*:** :*****::**    *:**: **::* .:.:  :.         ***::  
 
WreV      ILQPFLLLIAIGLSRLGI-RYWLGDTYQRI------LHQNTLAKVLIYGAGNAGRQLAGA 157 
WbpM      FNYWWLSMLLIGGLRLAMRQYFMGDWYSAVQSVPFLNRQDGLPRVAIYGAGAAGNQLVAA 179 
          :   :* :: **  **.: :*::** *. :       :*: * :* ***** **.**..* 
 
WreV      LTNSAELNVVGYLDDDPRLKGGIMGGLPIYDPSDLPVLAETLGVHNVLLALPSASRQRRN 217 
WbpM      LRLGRAMRPVAFIDDDKQIANRVIAGLRVYTAKHIRQMIDETGAQEVLLAIPSATRARRR 239 
          *  .  :. *.::*** ::   ::.** :*  ..:  : :  *.::****:***:* **. 
 
WreV      EILEHIRKARVNVRTLPDLTALAQGRVAVSDIRELEIEDLLGREAVAPRQELLDKAMRNK 277 
WbpM      EILESLEPFPLHVRSMPGFMDLASGRVKVDDLQEVDIADLLGRDSVAPRKELLERCIRGQ 299 
          **** :.   :.**::* :  **.*** *.*::*::* *****::****:***::.:* : 
 
WreV      VVMVTGAGGSIGGELCRQILRNAPSSLILIDQNEFALYNIHAELLKLAEVYKHEGLQIVP 337 
WbpM      VVMVTGAGGSIGSELCRQIMSCSPSVLILFEHSEYNLYSIHQELERRIK-RESLSVNLLP 358 
          ************.******:  :** ***:::.*: **.** ** :  :  :  .::::* 
 
WreV      ILCSVRDQDRMEHIMESWRPQTLYHAAAYKHVPLVEHNAVEGIKNNVMGTLITARAANKY 397 
WbpM      ILGSVRNPERLVDVMRTWKVNTVYHAAAYKHVPIVEHNIAEGVLNNVIGTLHAVQAAVQV 418 
          ** ***: :*: .:*.:*: :*:**********:**** .**: ***:*** :.:** :  
 
WreV      GVSNFVLISTDKAVRPTNVMGASKRLAEMVLQALAAELTA----------DRLRTNFSMV 447 
WbpM      GVQNFVLISTDKAVRPTNVMGSTKRLAEMVLQALSNESAPVLFGDRKDVHHVNKTRFTMV 478 
          **.******************::***********: * :           .  :*.*:** 
 
WreV      RFGNVLGSSGSVVPLFRQQIKEGGPVTLTHPKITRYFMTISEASQLVIQAGAMAEGGDVF 507 
WbpM      RFGNVLGSSGSVIPLFREQIKRGGPVTVTHPSITRYFMTIPEAAQLVIQAGSMGQGGDVF 538 
          ************:****:***.*****:***.******** **:*******:*.:***** 
 
WreV      LLDMGEPVRIADLARKMVELSGLTVRDVDNPEGDIELAVTGLRPGEKLYEELLIGDNPET 567 
WbpM      VLDMGPPVKILELAEKMIHLSGLSVRSERSPHGDIAIEFSGLRPGEKLYEELLIGDNVNP 598 
          :**** **:* :**.**:.****:**.  .*.*** : .:***************** :  
 
WreV      TEHPRIMKAREDFLFWAELSKKLNSLNASLDRNDMVAARATLAELVSGYSSTGEVSDLAF 627 
WbpM      TDHPMIMRANEEHLSWEAFKVVLEQLLAAVEKDDYSRVRQLLRETVSGYAPDGEIVDWIY 658 
          *:** **:*.*:.* *  :.  *:.* *:::::*   .*  * * ****:  **: *  : 
 
WreV      TGAETNPAHEDVNALASGAGNQLRTTGA 655 
WbpM      RQRRREP--------------------- 665 
             . :*                      
 
Figure 11. (A) 
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B 
 
WreQ      ---MRCLVTGAAGFVGSPLVKRLHAEKIYDLVATTRSQTPAFPPEVAHFPIEITGGTDWT 57 
WbpV      MTRHNVLVTGATGFIGAALVNSLCSSGQYKVWAGCRRRGGAWPRGVTPLLLGELGSSVVW 60 
              . *****:**:*: **: * :.  *.: *  * :  *:*  *: : :   *.:    
 
WreQ      AALEGVDVIVHLAARVHIMNDRAADPLAEFRRTNTAAALNLAEQAASAGVKRFVFVSTIK 117 
WbpV      DAESAIDTVVHCAARVHVMSETASDPLVEFRKANVQGTLDLAREAVSRGVRRFIFISSIK 120 
           * ..:*.:** *****:*.: *:***.***::*. .:*:**.:*.* **:**:*:*:** 
 
WreQ      VNGE--ENDRPFRHDDRPKPIDPYGISKLECEIGLREIAARTGMEVVIIRPPLVYGPGAR 175 
WbpV      VNGEGTEPGRPYTADSPPNPVDPYGVSKREAEQALLDLAEETGLEVVIIRPVLVYGPGVK 180 
          ****  *  **:  *. *:*:****:** *.* .* ::* .**:******* ******.: 
 
WreQ      GNFALLVNLVRKKLPLPFASLKNHRTLVAVQNLVDLIIACATHPAAPGEIFLAGDGEDLS 235 
WbpV      ANVQTMMRWLKRGVPLPLGAIHNRRSLVSLDNLVDLIITCIEHPAAVGQVFLVSDGEDLS 240 
          .*.  ::. ::: :***:.:::*:*:**:::*******:*  **** *::**..****** 
 
WreQ      TPALIRGIAAGLGVKPMLVPFPPALLQMAAKALGKEAVYQRLCGSLQVDITRARDVLGWS 295 
WbpV      TTELLRRMGRALGAPARLLPVPASWIGAAAKVLNRQAFARRLCGSLQVDIMKTRQVLGWT 300 
          *  *:* :. .**.   *:*.* : :  ***.* ::*. :********** ::*:****: 
 
WreQ      PVVTPREGLKLAVE------ 309 
WbpV      PPVGVDQALEKTARSFLDRQ 320 
          * *   :.*: :..       
Figure 11. Clustal alignments of R. etli protein WreV and WreQ with homologs in 
Pseudomonas aeruginosa. Shaded areas indicate characteristic motifs. (A) Alignment of the 
predicted protein sequence of WreV (655 aa) with WbpM (665 aa) of Pseudomonas aeruginosa 
PAO1 (O5). WbpM is a characterized UDP-GlcNAc 4,6 dehydratase It belongs to a group of 
long-chain dehydratases that catalyze the same reaction and are characterized by the GXXGXXG 
motif for NAD(P) binding and the group-specific SMK catalytic triad. WreV belongs to this 
group by sequence similarity. (B) Alignment of the predicted protein sequence of WreQ (309 aa) 
and WbpV (320 aa) of P. aeruginosa O6. Both proteins belong to the short chain 
dehydratase/reductase (SDR) superfamily. They possess the GXXGXXG motif and the typical 
SYK catalytic triad found in most SDR enzymes. 
J. R. etli wreQ mutant and suppression of this mutant 
A R. etli mutant strain (CE166) carrying a Tn5 transposon in the wreQ gene locus 
exhibits an altered LPS phenotype when analyzed by SDS-PAGE. CE166 (wreQ::Tn5) makes 
LPS I (O-antigen containing LPS) of normal size, but the abundance is only about 40% of that in 
the wildtype strain (CE3) (35). Characterization of the O antigen from CE166 showed that 
QuiNAc was replaced by its 4-keto derivative ADHexu, which is the proposed intermediate in 
QuiNAc synthesis (19). This observation led to the inference that wreQ encodes the 4-reductase 
for reducing ADHexu to QuiNAc (19). 
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Further chemical analysis of sugar linkage revealed that the ADHexu residue in CE166 
was located at the same position as QuiNAc in the CE3 LPS. Based on the prediction that 
QuiNAc is the first sugar of the O antigen in CE3, it is reasonable to assume that ADHexu is the 
first O antigen sugar in the CE166. The fact that CE166 makes an O antigen of normal length 
indicates that, first, the initiating GTase (putatively WreU) must be able to transfer the ADHexu-
1-P intermediate, as the authentic QuiNAc-1-P, to the lipid carrier Und-P; second, the GTase that 
catalyzes the second step of O-antigen biosynthesis must be able to recognize ADHexu as an 
acceptor for attaching the second sugar, in addition to the proposed acceptor QuiNAc. 
However, the reduced amount of LPS I in CE166 suggests that ADHexu is less efficient 
in the catalysis. It is possible that the activity of one or more enzymes involved in O-antigen 
biosynthesis is affected by the difference between ADHexu and QuiNAc. Candidates include the 
initiating GTase (putatively WreU) and the GTase for the subsequent catalytic steps. 
The amount of LPS I can be restored to nearly wildtype level by introducing into strain 
CE166 recombinant plasmids that contain a 7.8-kb stretch of the R. etli CE3 lps genetic region α 
even though this suppressing DNA does not carry the wreQ gene (35). However, the QuiNAc 
residue is still replaced in the resulting strain by ADHexu (19,35). So, the phenomenon was 
referred to as extragenic suppression, but not complementation. The mechanism of the 
suppression is unclear. One possibility is that the suppression is due to the multicopy dosage of a 
gene or genes in the 7.8-kb DNA fragment that promote the catalysis. 
The R. etli wreQ::Tn5 mutant strain CE166 provides a useful tool for in vivo study of the 
initial step of O-antigen biosynthesis, especially for identifying the gene products affected by the 
absence of QuiNAc. 
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WreG      MRVLHFFKTYWPDTFGGVERTIHAIAKGTQKHGICSEVLSLSPSPDTNTMLFDGHMAYKA 60 
WbdC      MRVLHVYKTYYPDTYGGIEQVIYQLSQGCARRGIAADVFTFSPDKDTGPVAYEDHRVIYN 60 
          *****.:***:***:**:*:.*: :::*  ::**.::*:::**. **  : :: * .    
 
WreG      KLDFEFASTGFSRDVFRHFRKLSKEADIIHFHFPWPLMDIVDLATRHGKPAIVTYHSDIV 120 
WbdC      KQLFEIASTPFSLKALKRFKLIKDDYDIINYHFPFPFMDMLHLSARPDARTVVTYHSDIV 120 
          *  **:*** ** ..:::*: :..: ***.:***:*:**::.*::*    ::******** 
 
WreG      KQKTLLKFYRPLMSRFLRGMDRIVATSPNYLQSSEVLRAFSSKTSVIPLGLSEGDYPVVA 180 
WbdC      KQKRLMKLYQPLQERFLSGVDCIVASSPNYVASSQTLKKYLDKTVVIPFGLEQQDVQHD- 179 
          *** *:*:*:** .*** *:* ***:****: **:.*: : .** ***:**.: *      
 
WreG      EEAKARWRSRLPKRFFLFIGVLRYYKGVHVLLEAARQTGFDVVLIGNGPTEDELKRTVRQ 240 
WbdC      PQRVAHWRETVGDKFFLFVGTFRYYKGLHILMDAAERSRLPVVVVGGGPLESEVRREAQQ 239 
           :  *:**. : .:****:*.:*****:*:*::**.:: : **::* ** *.*::* .:* 
 
WreG      QNLSNVHFLGGLPDADKVAILDLSLGLVFPSHLRSEAFGLSLVEAAMRGKPMISCEIGTG 300 
WbdC      RGLSNVMFTGMLNDEDKYILFQLCRGVVFPSHLRSEAFGITLLEGARFARPLISCEIGTG 299 
          : **** * * * * **  :::*. *:************::*:*.*  .:*:******** 
 
WreG      TSFVNLDGETGLVIPPNDTTALSQAMARLWNDDPLAISYGVNARQRYEVNFTAERMAQSY 360 
WbdC      TSFINQDKVSGCVIPPNDSQALVEAMNELWNNEETSNRYGENSRRRFEEMFTADHMIDAY 359 
          ***:* *  :* ******: ** :** .***::  :  ** *:*:*:*  ***::* ::* 
 
WreG      AELYRNVAGSR- 371 
WbdC      VNLYTTLLESKS 371 
          .:** .:  *:  
Figure 12. Clustal alignment the predicted sequence of R. etli CE3 protein WreG with 
WbdC of E. coli serotype O8. WbdC has been characterized in vitro to be a mannosyltransferase. 
It catalyzes the transfer of mannose from GDP-mannose to the GlcNAc residue of a GlcNAc-PP-
lipid acceptor. 
K. Addition of the second sugar residue in O-antigen biosynthesis in R. etli CE3 
In the O-antigen of R. etli CE3, a mannose is attached to the non-reducing end of 
QuiNAc (12). The gene encoding the GTase for adding this mannose residue has been assigned to 
wreG, which is located in the chromosomal O-antigen genetic cluster (12). WreG is homologous 
to the mannosyltransferase WbdC of E. coli O8 and O9a (Fig. 12), which has been shown to add 
mannose to the GlcNAc moiety of a lipid-linked GlcNAc acceptor in vitro (44). In R. etli CE3, 
WreG may catalyze the second step of O-antigen biosynthesis by transferring mannose to the 
QuiNAc moiety of Und-PP-QuiNAc, the predicted first O-antigen biosynthesis intermediate.  
The success of this step should depend on whether the preceding steps have occurred 
normally. Therefore, it can be used to validate the in vitro investigation of the initial step(s). 
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L. Hypotheses and Aims 
The overall goal of this dissertation is to elucidate the initial step of O-antigen 
biosynthesis in R. etli CE3. This initial step includes not only the initiation reaction catalyzed by 
the initiating GTase, but also reactions that lead to the synthesis of the putative first sugar 
QuiNAc. Evidence from previous genetic studies and from sequence similarities to other proteins 
could not provide a definitive answer for how O-antigen biosynthesis is initiated in R. etli CE3. 
Specifically, the exact reactions and the order in which the involved enzymes exert their activity 
remain to be defined. Based on the available information, two hypotheses are proposed and will 
be tested by a combination of in vitro and in vivo approaches (Fig. 13 and Fig. 14). 
Hypothesis 1: The nucleotide sugar donor of QuiNAc is UDP-QuiNAc, which is 
synthesized from UDP-GlcNAc following the proposed two-step pathway (Fig. 10). WreQ 
catalyzes the second step by reducing UDP-ADHexu to UDP-QuiNAc. WreU initiates O-antigen 
biosynthesis by transferring QuiNAc-1-P from UDP-QuiNAc to Und-P, resulting in the first O-
antigen intermediate Und-PP-QuiNAc, which then serves as the acceptor for the second sugar 
mannose, transferred by WreG (Fig. 13A and Fig. 14A).  
Hypothesis 2: After UDP-ADHexu is synthesized following the first step of the proposed 
synthesis pathway for UDP-QuiNAc (Fig. 10), WreU initiates O-antigen biosynthesis by 
transferring ADHexu-1-P from UDP-ADHexu to Und-P. The resulting Und-PP-ADHexu is 
reduced by WreQ to Und-PP-QuiNAc, which is the same result of the initial steps as in 
hypothesis 1. From that point onward, the remaining steps of O-antigen biosynthesis would be the 
same in both hypotheses (Fig. 13B and Fig. 14B). 
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Figure 13. The two hypotheses of O-antigen initiation in R. etli CE3. Reactions in each hypothesis and the enzyme that catalyzes each reaction 
are indicated. In both hypotheses, reactions (1) and (4) are the same. Reaction (1) is the conversion of UDP-GlcNAc to UDP-ADHexu, catalyzed 
by the predicted 4,6-dehydratase WreV. Reaction (4) is the addition of the second O-antigen sugar mannose to the first O-antigen intermediate 
Und-PP-QuiNAc. The two hypotheses differ in reactions (2) and (3). (A) In hypothesis 1, ADHexu is reduced to QuiNAc on the UDP linkage by 
WreQ and then QuiNAc-1-P is transferred by WreU. (B)  In hypothesis 2, ADHexu-1-P is transferred by WreU first and then ADHexu is reduced 
to QuiNAc by WreQ on the Und-PP linkage. 
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Hypothesis 1 was favored initially because, first, it includes the proposed biosynthetic 
pathway of UDP-QuiNAc; second, it allows QuiNAc synthesis to occur on a nucleoside 
diphosphate linkage in all steps, which is the convention for most sugar synthesis (36). It is highly 
unusual, if not unprecedented, for sugar synthesis to be completed after transfer of an 
intermediate form to a lipid, as proposed in hypothesis 2. However, both hypotheses can account 
for the phenotype of strain CE166 (wreQ::Tn5 mutant). 
Under hypothesis 1, CE166 phenotype may be explained as follows. Although the 
preferred substrate of WreU is UDP-QuiNAc, it has a relaxed specificity and can use UDP-
ADHexu as substrate in CE166 in which UDP-ADHexu cannot be reduced to UDP-QuiNAc. 
However, the activity of WreU is much lower with UDP-ADHexu, which leads to slower O-
antigen initiation reaction and eventually a lower amount of LPS I.  
Under hypothesis 2, CE166 phenotype is explained differently, as follows. Because 
WreU uses UDP-ADHexu as the substrate to initiate O-antigen biosynthesis, its activity should 
not be affected in the wreQ mutant. However, WreG may greatly prefer the acceptor Und-PP-
QuiNAc rather than Und-PP-ADHexu for attaching the second O-antigen sugar mannose. 
Because only Und-PP-ADHexu is available as an acceptor substrate in CE166 (not being able to 
convert it to Und-PP-QuiNAc), WreG may catalyze mannose addition so slowly that it limits the 
rate of O-antigen biosynthesis and leads eventually to a lower amount of LPS I. 
 
Specific aims of this dissertation are as follows: 
Aim 1: To investigate the proposed UDP-QuiNAc biosynthetic pathway using a 
biochemical approach in vitro, and synthesize UDP-QuiNAc for use in the study of the initial step 
of O-antigen biosynthesis. Achievement of this aim is summarized in Chapter Two.  
Aim 2: To elucidate the initial step of O-antigen biosynthesis in R. etli CE3. Specifically, 
to investigate the activity of enzymes proposed to be involved in the initial step, to deduce the 
order in which they exert their activity in vivo, and to confirm that QuiNAc is the first sugar of 
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the O antigen of R. etli CE3. Progress toward this aim and interpretation of results are presented 
in Chapter Three. 
 
Figure 14. Schematic diagram showing the reactions in each hypothesis. (A) Hypothesis 1. (B) 
Hypothesis 2. Each hypothesis contains 4 reactions, which are indicated by numbers (1), (2), (3) 
and (4). The lipidated compounds are represented by roman numbers: I, Und-PP-ADHexu; II, 
Und-PP-QuiNAc; III, Und-PP-ADHexu. The localization of putative enzymes WreV, WreU, 
WreQ and WreG are based on computational predictions and similarity to homologous proteins. 
In this figure, no attempt is made to depict speculated interactions between the proteins. 
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CHAPTER TWO: IN VITRO BIOSYNTHESIS AND CHEMICAL IDENTIFICATION 
OF UDP-QUINAC 
A. Introduction 
Many rare sugars are found in the polysaccharide structures coating bacterial cell surfaces. 
A moderately rare example is QuiNAc, which so far has been found exclusively in the 
lipopolysaccharides (LPSs) or capsular polysaccharides of bacteria. Although confined to bacteria, 
it is found in numerous species, including ones belonging to the genera Pseudomonas and 
Rhizobium (4,45). 
The QuiNAc residue of LPS in Rhizobium etli strain CE3 may play an important role in 
the biology of this bacterium. An R. etli mutant strain (CE166) carrying a Tn5 transposon in the 
wreQ gene locus (formerly designated lpsQ) fails in the infection stage of symbiosis with legume 
hosts. This mutant has much less O-antigen-containing LPS (LPS I) than normal (only 40% of the 
wild-type value) and its O antigen lacks QuiNAc (6,35). The QuiNAc is replaced in this mutant 
by its 4-keto derivative, ADHexu (19). The deficiency in O-antigen amount, but not the absence 
of QuiNAc, can be suppressed by introducing into this strain recombinant plasmids that share a 
7.8-kb stretch of the R. etli CE3 lps genetic region α, even though this suppressing DNA did not 
carry the genetic region mutated in strain CE166. Because QuiNAc is still replaced in the 
resulting strain by ADHexu, the effect of just this abnormality is thereby revealed. The mutant 
genetically suppressed in this way infects slowly and resulting root nodules are widely dispersed 
(35). This result suggests that the symbiotic role of LPS may require a specific structural feature 
conferred by QuiNAc. 
QuiNAc has been proposed to be the first sugar of the O antigen of R. etli CE3 and the O-
antigen repeating unit in Pseudomonas aeruginosa O6 (21,43,46). However, these inferences lack 
evidence from biosynthesis of the polysaccharide in vitro. One obstacle to such studies is that the 
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expected biosynthetic donor of the QuiNAc residue, UDP-QuiNAc, has never been produced in 
vitro. 
The proposed biosynthetic pathway of UDP-QuiNAc, based on studies in R. etli CE3 and 
in P. aeruginosa O6 (19), involves two steps. In the first step, the precursor UDP-GlcNAc is 
converted by a 4,6-dehydratase to its 4-keto-6-deoxy derivative, UDP-ADHexu. This reaction has 
been reproduced in vitro by use of several homologous enzymes (37-40,47). It is the common 
first step in synthesizing many UDP-6-deoxy-sugars from UDP-GlcNAc (36).  
In the proposed second step, the 4-keto intermediate UDP-ADHexu is further converted 
to UDP-QuiNAc by a 4-reductase. This reaction and an enzyme to catalyze it have never been 
demonstrated in vitro. It has been proposed that the R. etli CE3 wreQ gene encodes the 4-
reductase for this step. This gene was previously designated lpsQ (19), but all genes involved in R. 
etli CE3 O-antigen biosynthesis have been assigned the symbol wre to conform with bacterial 
polysaccharide genetic nomenclature (21). The predicted amino acid sequence suggests that 
WreQ belongs to the short chain dehydratase/reductase (SDR) superfamily, characterized by its 
GXXGXXG nucleotide-binding motif and the SYK catalytic triad (19,42). As mentioned above, 
chemical analysis of O antigen from the symbiosis-deficient wreQ null mutant showed that 
QuiNAc was replaced by its 4-keto derivative at the same position (19), which supported that 
WreQ is the 4-reductase for the last step in QuiNAc synthesis.  
P. aeruginosa serotype O6 contains QuiNAc in the O antigen of its B-band LPS. A wreQ 
gene homolog, wbpV, was found in its B-band O antigen gene cluster. Disruption of the wbpV 
gene abrogates O-antigen biosynthesis (43). P. aeruginosa strains (O6 and PAO1) also contain 
the wbpM gene which encodes a UDP-GlcNAc 4,6-dehydratase (43). The enzymatic activity of 
WbpM (PAO1) has been biochemically demonstrated in vitro (37,39). The R. etli CE3 genome 
contains a wbpM gene homolog designated wreV. The gene products of both wbpM and wreV 
belong to a family of long-chain dehydratases that possess amino-terminal transmembrane 
domains and the SMK catalytic triad (as opposed to SYK found in the SDR family). A logical 
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prediction is that these gene pairs (wreV and wreQ in R. etli CE3, wbpM and wbpV in P. 
aeruginosa O6) encode the enzymes needed to synthesize QuiNAc. 
In the work presented in this chapter, the R. etli CE3 WreQ protein was purified and its 
enzymatic activity was investigated in vitro. The nucleotide-sugar product of the WreQ-catalyzed 
reaction was chemically identified to be UDP-QuiNAc. The results confirmed that WreQ can act 
as a 4-reductase and provide the first demonstration of UDP-QuiNAc synthesis in vitro. 
 
B. Site-directed mutagenesis of R. etli wreV and wreQ gene 
In both of the hypotheses presented in Chapter One· L, QuiNAc synthesis begins with the 
4,6-dehydration of the precursor UDP-GlcNAc, which is proposed to be catalyzed by WreV in R. 
etli CE3. Disruption of the wreV gene is expected to abolish QuiNAc synthesis. Consistent with 
this prediction, a previous isolated mutant (strain CE168) carrying the transposon Tn5 in the 
wreV gene locus completely lacked LPS I (6). The wreQ::Tn5 mutant CE166 has been thoroughly 
investigated in previous studies (19,35) and its phenotype was presented in Chapter One· J. 
Because Tn5 insertions tend to have polar effects (48,49), wreV and wreQ genes were mutated 
separately by insertion of nonpolar antibiotic-resistance cassettes in this study. 
Mutagenesis of wreV gene— the wreV gene was disrupted by deleting the sequence 
between two internal PstI restriction sites and inserting either a gentamicin resistance cassette 
(Gm) or a kanamycin resistance cassette (Km). This approach has been shown to not cause polar 
effects on genes downstream in an operon (50). The resulting mutant strains CE568 (wreV::Gm) 
and CE569 (wreV::Km) showed a lack of LPS I (LPS I-) phenotype (Fig. 15A, lane 3 and 4). Both 
CE568 and CE569 can be complemented by introducing the wildtype wreV gene on the 
pFAJ1708 vector (51), as shown by the reappearance of the LPS I band (Fig. 15B, lane 3 and 5). 
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Figure 15. SDS-PAGE analysis of the LPS phenotype of the wreV mutant strains and 
complemented strains. (A) R. etli wreV mutants are devoid of LPS I. Lanes: lane1, CE3 
(wildtype); lane 2, CE168 (wreV::Tn5); lane 3, CE568 (wreV::Gm); lane 4, CE569 (wreV::Km). 
(B) R. etli wreV mutants can be complemented by wildtype wreV gene. Lanes: lane 1, CE3; lane 2, 
CE568; lane 3, CE568/pTL7; lane 4, CE569; lane 5, CE569/pTL7. pTL7 is a pFAJ1708 vector 
carrying the wildtype wreV gene. 
Mutagenesis of wreQ gene— the wreQ gene was disrupted by the same deletion-insertion 
approach as described above. The wreQ::Km mutant CE572 was obtained but no wreQ::Gm 
mutant could be isolated. Strain CE572 showed the same LPS phenotype—reduced LPS I amount, 
as the wreQ::Tn5 mutant CE166 when analyzed by SDS-PAGE (Fig. 16A, lane 3), and it can be 
complemented by the wildtype wreQ gene (Fig. 16B, lane 3). This result confirmed that the 
reduced LPS I amount is caused by the mutation in the wreQ gene. However, since the LPS 
composition of strain CE572 was not investigated, CE166 (wreQ::Tn5) will be used as the wreQ 
mutant strain in the following experiments in this dissertation.  
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Figure 16. SDS-PAGE analysis of the LPS phenotype of the wreQ mutant strains and 
complemented strains. (A) R. etli wreQ mutants show a reduced LPS I amount compare to the 
wildtype. Lanes: lane 1, CE3 (wildtype); lane 2, CE166 (wreQ::Tn5); lane 3, CE572 (wreQ::Km). 
(B) Strain CE572 complemented with wildtype wreQ gene. Lanes: lane 1, CE3; lane 2, CE572; 
lane 3, CE572/pJBQ3. pJBQ3 is a pFAJ1708 vector carrying the wildtype wreQ gene (19). 
C. Cloning, Expression and Purification of WreQ 
The wreQ gene was amplified from chromosomal DNA of R. etli CE3 and cloned into the 
pET15b vector. The resultant plasmid encodes a WreQ protein with an amino terminal six-
histidine (His6) tag. Following overexpression, this His6-WreQ protein was purified from the 
soluble fraction by nickel-affinity chromatography (Fig. 17A). 
The modified wreQ gene (His6-wreQ) was determined to be functional in vivo due to its 
ability to complement the R. etli wreQ::Tn5 mutant strain CE166. In the complemented mutant, 
the level of O-antigen-containing LPS (LPS I) was restored to normal (Fig. 18A), and the 
presence of quinovosamine (derived from QuiNAc) in the LPS was confirmed by sugar 
composition analysis (Fig. 18B). The WreQ homolog WbpV from P. aeruginosa O6 also 
complemented the same mutant (Fig. 18A, C). All of these results match those reported 
previously (19) when the wild-type wreQ gene was used to complement this same mutant. 
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Figure 17. Commassie blue-stained SDS-PAGE (15% gel) showing purified proteins used 
for in vitro biosynthesis of UDP-QuiNAc. (A) His6-WreQ. (B) WbpM-His-S262. The apparent 
size of the purified His6-WreQ protein agreed with its predicted size of 35.3 kDa. The apparent 
size of the purified WbpM-His-S262 protein is consistent with the published result (37) (46.1 
kDa). 
D. Generation of WreQ substrate—UDP-ADHexu 
Attempts to express the putative UDP-GlcNAc 4,6-dehydratase WreV in E. coli for 
purification and characterization of its activity have been unsuccessful. To generate the putative 
substrate UDP-ADHexu for investigating the enzymatic activity of WreQ, a soluble truncated 
version of the WbpM protein, His-S262 (37), was chosen to catalyze the 4,6-dehydration of UDP-
GlcNAc. The conversion of tritium (3H)-labeled UDP-GlcNAc to a new compound upon the 
addition of purified WbpM-His-S262 protein (Fig. 17B) was shown by thin layer chromatography 
(TLC)-autoradiography (Fig. 20, lane 1 and 2). The same result was obtained from a 
nonradioactive reaction as shown by TLC with thymol staining (Fig. 19, lane 1 and 2). The new 
compound was purified from unstained TLC plates (Fig. 19, lane 3). Its 1D and 2D 1H-NMR 
spectra (discussed below) agreed with the results of previous studies on the WbpM homolog 
Cj1120c (PglF) (39). The evidence that this product is the UDP-ADHexu will be presented later 
in this chapter. 
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Figure 18. Complementation of the Rhizobium etli wreQ::Tn5 mutant strain, CE166. (A) 
Silver-stained SDS-PAGE (18% gel) of LPS samples from whole-cell lysates. Lanes: lane 1, CE3; 
lane 2, CE166; lane 3, CE166/pLS31; lane 4, CE166/pJB7; lane 5, CE166/pJB8. LPS I, O-
antigen-containing LPS; LPS II, core oligosaccharide-Lipid A lacking O antigen. (B, C) Relative 
content of QuiNAc among the sugars of crude LPS as revealed by GC analysis after conversion 
of sugars to alditol acetates. CE3, wild-type R. etli strain; CE166, R. etli strain with a Tn5 
insertion in wreQ; CE166/pLS31, CE166 strain carrying pLS31 vector which expresses His6-
WreQ; CE166/pJB7 and CE166/pJB8, CE166 strain carrying pJB7 or pJB8 plasmids, each 
carrying the wbpV gene. QuiN, quinovosamine. 
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Figure 19. Thymol-stained TLC plate showing the purification of UDP-ADHexu. Lanes: lane 
1, UDP-GlcNAc, 25 nmol; lane 2, WbpM-reaction sample, 10 nmol total nucleotide sugar; lane 3, 
purified UDP-ADHexu candidate, estimated amount 5 nmol. 
E. Substrate conversion by WreQ 
A two-step reaction was carried out to test the enzymatic activity of WreQ. Following the 
first-step reaction catalyzed by WbpM, purified His6-WreQ protein and NAD(P)H were added to 
initiate the second-step reaction. A new compound later shown to be UDP-QuiNAc was produced 
(Fig. 20, lane 3 and 4). Both the WreQ enzyme and NAD(P)H were required to produce this new 
compound (Fig. 20, lane 6 and 7). WreQ did not use UDP-GlcNAc as substrate; i.e., no 
conversion occurred in the absence of WbpM (Fig. 20, lane 5). 
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Figure 20. Autoradiograms of TLC-separated WbpM-WreQ reaction and control reactions. 
Lanes: lane 1, no enzymes were added to the nucleotide sugar substrate UDP-GlcNAc; lane 2, 
WbpM reaction for synthesizing UDP-ADHexu; lane 3, WbpM-WreQ reaction, for synthesizing 
UDP-QuiNAc; lane 4, NADPH in place of NADH; lane 5, negative control, no WbpM; lane 6, 
negative control, no WreQ; lane 7, no NAD(P)H. NMR analysis confirmed the identities of the 
spots as follows: Spot I, UDP-GlcNAc; Spot II, UDP-ADHexu; Spot III, UDP-QuiNAc. 
F. GC-MS analysis of the WbpM-WreQ reaction product 
To gain initial evidence that UDP-QuiNAc was synthesized in the WbpM-WreQ coupled 
reaction, the reaction mixture was treated at 100 °C with acid to release the sugars from the UDP 
linkages. The resulting compounds were reduced and acetylated to convert sugars into deuterated 
alditol acetates, followed by combined gas chromatography-mass spectrometry (GC-MS) analysis 
(Fig. 21A, B). Pure UDP-GlcNAc was analyzed after the same treatment as a control (Fig. 21C, 
D). 
When the WbpM-WreQ reaction sample was analyzed, a major peak eluted at 26.61 min 
(Fig. 21A). It fragmented into ions with m/z ratios 85, 103, 145 which identified it as a 2-amino 
sugar, and ions with m/z ratios 201, 260, 302 (Fig. 21B), which were 58 mass units smaller than 
the corresponding ions of the alditol acetate derived from GlcNAc (Fig. 21D). This difference 
agreed exactly with predicted differences at the C6 position, where the GlcNAc derivative is 
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CH2OCOCH3 (molecular mass=73) and QuiNAc derivative is CH3 (molecular mass=15). This 
data supported the existence of the QuiNAc moiety in the reaction mixture, as expected if UDP-
QuiNAc is produced. 
 
Figure 21. (A, B)  
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Figure 21. GC-MS analysis of chemical derivatives after converting sugars to alditol 
acetates. (A) GC profile of the WbpM-WreQ reaction sample after alditol acetate treatment. (B) 
MS spectrum of the QuiNAc derivative peak in panel A. inset, predicted MS fragmentation 
patterns of the alditol acetates derived from QuiNAc. (C) GC profile of UDP-GlcNAc after 
alditol acetate treatment. (D) MS spectrum of the GlcNAc derivative peak in panel C. inset, 
predicted MS fragmentation patterns of the alditol acetates derived from GlcNAc. MS peaks 
corresponding to the predicted fragmentation pattern were shown with numbers above. The peak 
designated with “&” in panel A and C is a common non-sugar peak. The peak designated with “#” 
in panel A may have resulted from other components in the enzyme reaction as it was not 
detected in panel C. 
G. NMR analysis of the WreQ-mediated production of UDP-QuiNAc 
Compounds in a non-radioactive WbpM-WreQ reaction mixture were separated by TLC, 
and the UDP-QuiNAc candidate was purified from an unstained TLC plate (Fig. 22). The purified 
compound was analyzed by one and two-dimensional NMR spectroscopy (Fig. 23 and Fig. 24). 
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Figure 22. Thymol stained TLC plate showing the purification of UDP-QuiNAc. Lanes: lane 
1, UDP-GlcNAc, 20 nmol; lane 2, WbpM-WreQ reaction sample, 20 nmol total nucleotide sugar; 
lane 3, purified UDP-QuiNAc candidate, estimated amount 7.5 nmol. 
Assignment of proton resonances of the WreQ reaction product utilized a combination of 
NOESY, TOCSY and COSY correlations. The 2D 1H-1H TOCSY experiment allowed 
establishing the resonance frequencies of all protons in the QuiNAc sugar ring (Fig. 23B). The 
UDP ribose ring protons were observed between 4.174 and 4.344 ppm and at 5.959 ppm. The one 
at 5.959 ppm was correlated to the uracil base proton at 7.935 ppm (not shown). The UDP 
resonances did not significantly change from UDP-GlcNAc to UDP-ADHexu and to UDP-
QuiNAc; they will not be discussed. Contaminants uncoupled from UDP-QuiNAc resonances 
were observed in small amounts in the UDP-QuiNAc sample as isolated spin systems at low 
intensity between 3.624 ppm and 3.814 ppm; at 1.677 and 2.144 ppm; and at 1.221 ppm (Fig. 
23B). The hexose protons assigned to the UDP-QuiNAc resonance chemical shifts (Table 1) are 
explained below. 
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Table 1. Summary of the proton chemical shifts and multiplet structures for the hexose ring 
of UDP-QuiNAc and UDP-ADHexu at 30 °C. Standard deviation of the chemical shift values is 
on the order of 0.004 ppm (as reported by Sparky). Accuracy of J-coupling constant estimates is 
±0.2 for for UDP-D-QuiNAc and ±0.6 Hz for UDP-2-acetamido-2,6-dideoxy-D-xylo-4-hexulose. 
Compound Proton Chemical shift (ppm) Multiplet structure 
J-coupling constants 
(Hz) 
UDP-QuiNAc H-1 5.422 1:1:1:1 quadruplet 3JH1,H2 = 3.6 
3JH1,P = 7.2 
H-2 3.978 unresolved overlapped 
multiplet 
H-3 3.723 1:2:1 triplet 3JH3,H4 = 9.8 
3JH2,H3 = 9.8 
H-4 3.231 1:2:1 triplet 3JH3,H4 = 9.3 
3JH4,H5 = 9.3 
H-5 3.977 unresolved overlapped 
multiplet 
 
H-6 1.271 1:1 doublet 3JH6,H5 = 6.0 
UDP-ADHexu[a] H-1 5.433 poorly resolved multiplet  
H-2 4.091 unresolved overlapped 
multiplet 
3JH3,H2 = 10.8 
H-3 3.803 doublet  
H-5 4.091 unresolved overlapped 
multiplet 
 
H-6 1.218 doublet 3JH6,H5 = 5.4 
[a] Due to a lower concentration of the latter sample the spectral quality did not allow confident 
measurement of the smaller 3J-coupling constants at H1 position. 
 
 
The methyl proton doublet centered at 1.271ppm was identified as H6 by comparison 
with the proton spectrum of UDP-GlcNAc, which shows the only methyl resonance at 2.044 ppm 
originating from its acetamido group. Inspection of the 2D 1H-1H COSY revealed that the 
neighbor of H6, the H5 proton, resonates at 3.977 ppm (Fig. 23C). The peak of H5 had significant 
asymmetry indicating overlapping resonances, and showed four COSY cross-peaks. 
The proton resonance at 5.442 ppm was assigned to be H1 by similarity to other sugar 
nucleotides (52). Inspection of the 2D 1H-1H NOESY correlation map (Fig. 23D) reveals a strong 
(and the only) NOE cross-peak of H1 at 5.442 and 3.977 ppm indicating that H5 must be 
overlapping with H2 at this chemical shift because H5 is too far away to produce NOE to H1. (In 
the COSY data the H1 resonance was mirrored into the 4.0 ppm region, thus obscuring the 
expected cross-peak with H2). 
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Figure 23. Structural determination for UDP-QuiNAc. (A) Structure and proton NMR 
resonance assignments of the reaction product deduced to be UDP-QuiNAc. (B-D), two 
dimensional 1H-1H TOCSY, COSY, NOESY analysis of UDP-QuiNAc: (B), 2D 1H-1H TOCSY 
correlation map for UDP-QuiNAc. (C) 2D 1H-1H COSY correlation map for UDP-QuiNAc. The 
experiment was acquired in real-time mode; therefore, all resonances with chemical shifts beyond 
water appear mirrored. (D) 2D 1H-1H NOESY correlation map for UDP-QuiNAc. 
Out of the two remaining resonances at 3.723 and 3.231 ppm, we assigned H4 to 3.231 
according to the following considerations: (1) the TOCSY cross-peak of H6-H3 is weaker 
comparatively to the H6-H4 cross-peak, in accord with the greater number of bonds separating 
H6 and H3 spins (Fig. 24A, top panel); (2) an opposite relationship is observed for TOCSY cross-
peaks of H1-H3 and H1-H4—the latter being the weakest of the two, corresponding to the greater 
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number of intervening bonds (Fig. 24A, bottom panel); (3) this resonance is absent in the 4-keto 
intermediate, which would not have a proton at position 4 (see Fig. 24B). 
The configuration of the H4 and H5 in UDP-QuiNAc was determined to be axial based 
on analysis of 3J-coupling constants. Both H3 and H4 are symmetrical triplets indicating identical 
3J-coupling constants of 9-10 Hz for all H2-H3, H3-H4, and H4-H5 pairs (Fig. 24B, top trace). 
The large value of the 3J-coupling constants is indicative of the axial orientation of coupled 
protons (53); therefore, we conclude that H4 and H5 are axial, which leads to the structure shown 
in the Fig. 23A, corresponding to the configuration of a QuiNAc ring. 
 
Figure 24. Assignment of proton chemical shifts for H3 and H4. (A) Strips of 2D 1H-1H 
TOCSY correlation map for UDP-QuiNAc and one-dimensional slices taken at frequencies of H6 
(top panel) and H1 (bottom panel) in indirect dimension demonstrating relative intensities of the 
cross-peaks. (B) Comparison of one-dimensional proton NMR spectra of purified UDP-QuiNAc 
(top trace) and UDP-ADHexu (bottom trace). 
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H. NMR analysis of the WreQ substrate for UDP-QuiNAc synthesis—UDP-ADHexu 
To confirm that the substrate in the WreQ-catalyzed reaction (second step) is truly UDP-
ADHexu, the product of the WbpM reaction (first-step) was purified and analyzed by NMR. 
Assignment of NMR signals was performed in a similar fashion as for the UDP-QuiNAc. The 
TOCSY correlation map demonstrated that the WbpM reaction product contains two isolated 
proton spin systems with signals of one assigned to H6 and H5 while the second spin system 
included H1, H2, and H3. The H2 and H5 resonances overlap in the same fashion as in the 
TOCSY spectra of UDP-QuiNAc (Fig. 25A), but the absence of a H6-H3 cross peak indicates a 
break in the continuous path for the TOCSY transfer from H6 to H3 due to the H4 proton missing 
in the 4-keto intermediate. 
Panel B of Fig. 24 compares the one-dimensional spectra of UDP-QuiNAc and the 
WbpM reaction product demonstrating the absence of the H4 signal in the 4-keto intermediate 
spectrum (bottom trace). Additionally, the H3 signal becomes a doublet indicating that H3 has 
only one 3J-coupling partner in this molecule, which must be H2. These findings confirm that the 
WbpM reaction product and substrate of WreQ was, indeed, UDP-ADHexu, with the structure 
and the proton assignment shown in Fig. 25, panel B. 
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Figure 25. Structural determination for UDP-ADHexu. (A) TOCSY correlation map obtained 
using a purified sample of the WbpM reaction product. (B) Molecular structure and proton NMR 
resonance assignments of UDP-ADHexu. 
I. Direct observation of the reaction progress by NMR 
Stability of the compounds in the NMR tube was directly assessed by comparison of one-
dimensional proton spectra acquired before and after two-dimensional experiments. Samples 
were found to be completely stable over the entire time of data acquisition. 
To gain information about reaction kinetics, we performed the enzyme incubation in an 
NMR spectrometer and directly monitored the WbpM-WreQ reaction progress. Initial 
accumulation of the UDP-ADHexu and its subsequent conversion into UDP-QuiNAc was 
monitored by 1H NMR spectroscopy at 30 °C. Fig. 26 shows an overlay of one-dimensional 
proton spectra taken during the reaction course. The initial reaction mixture (black trace) 
contained UDP-GlcNAc, NADH, and purified WreQ, but no WbpM. Addition of WbpM led to 
quick accumulation of UDP-ADHexu (reflecting 4,6-dehydratase activity of WbpM) as indicated 
by appearance of the new H6 methyl proton doublet centered at 1.217 ppm. Activity of WreQ led 
to subsequent conversion of UDP-ADHexu to UDP-QuiNAc that was detected by the appearance 
of its H6 methyl doublet centered at 1.271 ppm (and decreasing H6 methyl signal of UDP-
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ADHexu). Because the predicted product UDP-QuiNAc retains the methyl group in position 6, 
the chemical shift change must reflect the modification of the hexose ring at position 4. The 
WbpM-catalyzed reaction was significantly faster than that catalyzed by WreQ. Most UDP-
ADHexu was produced within the first 10 minutes (black to blue traces), while subsequent slow 
conversion to UDP-QuiNAc continued during overnight incubation and, even then, was not 
complete (blue to red traces). 
 
Figure 26. One-dimensional proton NMR spectra obtained from the reaction mixture at 
different incubation times. A broad resonance at 1.241 ppm is due to methyl groups of the 
detergent Triton X-100 present in the reaction mixture. This reaction was performed with 1 mM 
UDP-GlcNAc, 1 mM NADH, 48 µg WbpM and 54 µg WreQ in a total volume of 300 µl. WbpM 
was added last to start the reaction. 
J. DISCUSSION 
Quinovosamine was first identified in bacterial polysaccharides more than 50 years ago 
(54,55). Attempts to establish the pathway of its biosynthesis foundered on the use of crude 
extracts and the problem of demonstrating a specific reaction by adding NADH to a crude extract 
(56). Only now, with the use of a genetic approach leading to a facile enzyme purification, has an 
enzymatic pathway for its synthesis been demonstrated in vitro. In this report, we present 
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evidence that UDP-QuiNAc can be synthesized in vitro from UDP-GlcNAc via the two steps 
proposed previously (19) (Fig. 10, Fig. 27). 
 
Figure 27. The proposed biosynthesis pathway of UDP-QuiNAc in Rhizobium etli CE3 and 
Pseudomonas aeruginosa O6. The P. aeruginosa O6 proteins are indicated in parentheses. 
The first step is catalyzed by UDP-GlcNAc 4,6-dehydratase, resulting in the 4-keto 
intermediate UDP-ADHexu. A soluble truncated version of the WbpM protein from P. 
aeruginosa was used in this study to catalyze this reaction in vitro (37). The R. etli CE3 wreV 
gene encodes a protein that is homologous to WbpM. An insertion mutation in wreV abolished O-
antigen biosynthesis in R. etli, and wbpM complemented this mutant (Fig. 28). Hence, WreV is 
inferred to be the 4,6-dehydratase responsible in R. etli for the first step of UDP-QuiNAc 
synthesis.  
The second step in Fig. 27 is catalyzed by a 4-reductase. Previous studies (19,35) 
suggested that wreQ encodes this enzyme in R. etli CE3. The in vitro reaction in this study 
confirmed this prediction. WreQ stereospecifically reduces the 4-keto intermediate to UDP-
QuiNAc, instead of its C-4 epimer UDP-N-acetyl-D-fucosamine (UDP-FucNAc). A homolog of 
WreQ in P. aeruginosa O6, encoded by wbpV, has been proposed to catalyze the same reaction 
(43). As predicted, the wbpV gene can complement the R. etli wreQ::Tn5 mutant (Fig. 18, A, C). 
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Figure 28. Pseudomonas aeruginosa wbpM gene can complement Rhizobium etli wreV 
mutant (CE568, ΔwreV). Silver-stained SDS-PAGE (18% gel) of LPS samples from whole-cell 
lysates. LPS I, O-antigen-containing LPS; LPS II, core oligosaccharide-Lipid A lacking O 
antigen. CE3, wild-type R. etli strain; CE568, R. etli strain with a gentamicin resistance cassette 
insertion in wreV (ΔwreV); CE568/pTL61, CE568 strain carrying plasmid pTL61 which 
expresses the full-length WbpM. 
The second reaction catalyzed by WreQ in Fig. 27 was relatively slow. The low activity 
may be an artifact of one or more features of the in vitro reaction. The His6-WreQ protein used in 
vitro has additional amino acids at the amino-terminus, which could be affecting the structure at 
the active site and slowing catalysis. Another consideration is that, during dialysis to reduce the 
concentration of imidazole used in purification of the His-tagged protein, the His6-WreQ protein 
precipitated in the dialysis tubing. It was found that adding detergent Triton X-100 alleviated the 
precipitation, but the presence of detergent (0.1% of reaction volume) may have affected the 
reaction rate. It is unclear why His6-WreQ precipitated during dialysis. One possible explanation 
is that WreQ normally associates with the membrane or other proteins in R. etli CE3 and that they 
are required for its stability. If that is the case, overproduction of WreQ in E. coli, which is devoid 
of its naturally-associating partner, may render it unstable. 
The pathway intermediate UDP-ADHexu was relatively stable. Although other 4-keto, 6-
deoxy sugars have been reported to be unstable (52,57-59), this 4-keto-6-deoxy derivative of 
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UDP-GlcNAc was able to withstand purification by TLC, and was stable for several days during 
NMR data acquisition. Thus, we were able to obtain both this intermediate and UDP-QuiNAc in 
stable, relatively pure form. 
Analysis of O-antigen mutants and the sequences of the wre genes for O antigen 
synthesis have prompted speculation that O-antigen biosynthesis in R. etli CE3 begins with 
reactions that result in 1-pyrophospho-QuiNAc attached to a lipid carrier (21). As noted in the 
introduction, a previous study showed that QuiNAc was replaced by its 4-keto derivative in the 
LPS of the wreQ::Tn5 mutant strain, CE166 (19). This observation leads to questions regarding 
the substrate specificities of WreQ and the putative GTase that catalyzes the initial sugar-lipid 
linkage. It is conceivable that the initiating GTase works better with UDP-ADHexu as substrate. 
If so, the resulting lipidated ADHexu may be a better substrate for WreQ than UDP-ADHexu. 
This also could explain the relatively slow catalysis of WreQ noted in this study. The compounds 
generated in vitro in this study provide an essential starting point for testing the speculations. 
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CHAPTER THREE: THE INITIAL STEP OF O-ANTIGEN BIOSYNTHESIS 
IN RHIZOBIUM ETLI CE3 
A. Introduction 
Despite tremendous structural variations, the biosynthesis of all characterized O antigens 
is believed to begin with a conserved initial step, which involves the formation of an Und-PP-
linked glycose by transfer of the sugar-1-P residue from an NDP-sugar to the lipid carrier Und-P. 
This step is catalyzed by an initiating GTase which differs from other GTases involved in O-
antigen biosynthesis in that it recognizes a hydrophobic lipid carrier rather than a sugar acceptor, 
and that it transfers the sugar-1-P residue rather than the sugar alone.  
The first O-antigen sugar in Rhizobium etli CE3 has been proposed to be QuiNAc, based 
on the following evidence. First of all, structural studies indicated that QuiNAc was linked to the 
non-reducing end of a Kdo (3-deoxy-D-manno-oct-2-ulosonic acid) residue (4,31) and 
biosynthetic/genetic studies strongly supported that this Kdo is part of the biosynthetic core of the 
LPS (5,32-34). Secondly, LPS composition analysis of O-antigen mutants that either lack O 
antigen completely or produce truncated O antigens that are in much lower amount (than the full-
length O antigen produced in WT) revealed that QuiNAc is always significantly less in amount 
than core-specific sugars such as galactose. This strongly suggested that QuiNAc is not a core 
sugar (12). Lastly, the first sugar of many O antigens is an amino sugar. Such is the case for most 
E. coli strains in which GlcNAc is the first sugar (26), and was recently demonstrated for 
Aeromonas hydrophila AH-3 in which O antigen is initiated with GalNAc (60). In addition, 
FucNAc and QuiNAc have been proposed to initiate the O repeating unit in Pseudomonas 
aeruginosa serotype O5 and O6, respectively (43,61). 
Based on mutational analysis, the wreU gene located on plasmid B is predicted to encode 
the initiating GTase for O-antigen biosynthesis in R. etli CE3 (12). The WreU protein is 
homologous to the C-terminal domain of WbaP (WbaPCT), which was shown to be a UDP-
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Gal:Und-P Gal-1-P transferase (29). Furthermore, the wreU::Km mutant strain (CE566) lacks the 
LPS I band when analyzed by SDS-PAGE. Sugar composition analysis of its LPS revealed the 
lack all O-antigen-specific sugars including QuiNAc (12). 
It is most straightforward to propose that WreU initiates O-antigen biosynthesis in R. etli 
CE3 by transferring QuiNAc-1-P from UDP-QuiNAc to Und-P. However, the LPS phenotype of 
wreQ::Tn5 mutant strain CE166 suggests that WreU is able to transfer ADHexu-1-P to Und-P, 
possibly from UDP-ADHexu, the intermediate in the UDP-QuiNAc synthesis. Thus, both UDP-
QuiNAc and UDP-ADHexu will be tested as potential substrates of WreU.  
R. etli WreQ was used in the form of purified enzyme in vitro towards synthesizing UDP-
QuiNAc, as described in Chapter Two. Although WreQ was able to catalyze the reduction of 
UDP-ADHexu to UDP-QuiNAc, the reaction it catalyzed was relatively slow. It raises the 
question of whether UDP-ADHexu is the natural substrate of WreQ in vivo. Considering that the 
initiating GTase (putatively WreU) may use UDP-ADHexu as substrate and transfer ADHexu-1-
P to Und-P, a possible alternative is that the true substrate of WreQ in vivo is Und-PP-ADHexu 
and WreQ reduces it to Und-PP-QuiNAc. In this scenario, it is very likely that UDP-QuiNAc has 
never been made in the cell. 
According to the structure of R. etli CE3 O antigen (4), if QuiNAc is the first O-antigen 
sugar, mannose is the second. The GTase for adding this Man residue was proposed to be 
encoded by the wreG gene, located within the chromosomal O-antigen genetic cluster. Several 
lines of evidence support this role of WreG (12): the primary sequence of WreG is highly 
homologous to the mannosyltransferase WbdC of E. coli O8 and O9a; the wreG mutant lacks the 
wild-type LPS I band and has no visible truncated LPS I band that can be resolved from LPS II 
on SDS-PAGE gels, suggesting that its O antigen is truncated at an early step; LPS sugar 
composition revealed that the wreG mutant lacks all other O-antigen specific sugars but contains 
QuiNAc (12). It is most straightforward to postulate that WreG normally adds mannose to the 
Und-PP-QuiNAc acceptor. However, WreG should be able to add mannose to the Und-PP-
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ADHexu acceptor as this reaction apparently occurs in CE166. Futhermore, a variation of 
hypothesis 2 is that WreG normally adds mannose to Und-PP-ADHexu before the reduction 
ADHexu to QuiNAc by WreQ. This possibility cannot be ruled out until further evidence is 
provided. 
Considering the possible enzymatic activities of WreU, WreQ and WreG, two hypotheses 
were formed for the initial step of O-antigen biosynthesis in R. etli CE3 as described in Chapter 
One· L. The overall aim of this chapter is to understand how O-antigen biosynthesis is initiated in 
R. etli CE3. Specific aims and reasoning are: 
1. To determine whether WreU is the initiating GTase and understand its nucleotide sugar 
substrate specificity. If WreU can use both UDP-QuiNAc and UDP-ADHexu as substrate but 
prefers UDP-QuiNAc, hypothesis 1 may be correct; If WreU only uses UDP-ADHexu as 
substrate, hypothesis 2 is favored. 
2. To determine whether WreQ can reduce Und-PP-ADHexu to Und-PP-QuiNAc. If it cannot, 
then hypothesis 1 is favored in which WreQ is a UDP-ADHexu 4-reductase, and hypothesis 2 
may not be correct. If it can, then WreQ is a Und-PP-ADHexu 4-reductase and hypothesis 2 
is possible. 
3. To determine whether WreG is a mannosyltransferase and understand its specificity to the 
acceptor substrate. In both hypotheses, WreG may transfer Man to the Und-PP-QuiNAc 
acceptor, but it should be able also to transfer Man to Und-PP-ADHexu. However, if WreG 
only transfers Man to the Und-PP-ADHexu acceptor, it will disprove hypothesis 1 and favor 
hypothesis 2. Specifically, it will indicate that WreQ reduces ADHexu to QuiNAc after the 
transfer of Man to ADHexu. 
  
Besides in vitro methods, the roles of proteins (enzymes) can be investigated in vivo 
through R. etli CE166 (wreQ::Tn5 mutant) suppression assays. The low amount of LPS I in 
CE166 can be brought to near WT level by introducing into this mutant a DNA fragment of the 
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chromosomal O-antigen genetic cluster on a plasmid. This DNA fragment did not contain the 
wreQ gene and the QuiNAc was still absent in the suppression strain. It was concluded that 
suppression was due to the multicopy dosage of a gene or genes (35). According to hypothesis 1 
and 2, the two enzymes whose activities are most probably affected in CE166 are WreU and 
WreG. However, the proposed mechanisms for the deficiency of O-antigen biosynthesis and the 
predicted methods for suppression are different between the two hypotheses, which are discussed 
below: 
Hypothesis 1 proposes that WreU prefers to use UDP-QuiNAc as substrate to initiate O-
antigen biosynthesis, although it can also use UDP-ADHexu for the same purpose in the 
wreQ::Tn5 mutant strain CE166 in which conversion from UDP-ADHexu to UDP-QuiNAc is 
blocked. Thus, WreU definitely causes the deficiency in O-antigen biosynthesis under this 
hypothesis. WreG may or may not prefer the acceptor Und-PP-QuiNAc to Und-PP-ADHexu for 
adding mannose, and it may or may not contribute to the deficiency in O-antigen biosynthesis. 
Anyhow, under hypothesis 1, CE166 is expected to be suppressed by introducing multiple copies 
of the wreU gene, as this is expected to increase the concentration of Und-PP-ADHexu, which is 
used by WreG to continue O-antigen biosynthesis. 
Hypothesis 2 proposes that WreU preferentially uses UDP-ADHexu as substrate. So, the 
activity of WreU is not expected to be affected in the wreQ::Tn5 mutant strain CE166. The 
deficiency in O-antigen biosynthesis should have nothing to do with WreU under this hypothesis, 
but instead may be caused by WreG as it may prefer the acceptor Und-PP-QuiNAc to Und-PP-
ADHexu for adding mannose. In this case, the activity of WreG is definitely affected in CE166 in 
which ADHexu is not reduced to QuiNAc and it is expected that CE166 can be suppressed by 
introducing multiple copies of the wreG gene.  
A variation derived from hypothesis 2 is that WreG prefers to add mannose to Und-PP-
ADHexu before the WreQ-catalyzed reduction of ADHexu to QuiNAc. Accordingly, the activity 
of WreG should not be affected in wreQ::Tn5 mutant strain CE166, and the deficiency in O-
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antigen biosynthesis may be caused by a downstream enzyme that recognizes QuiNAc. In this 
scenario, CE166 is not expected to be suppressed by introducing either the wreG or the wreU 
gene. 
The in vivo suppression of the wreQ::Tn5 mutant strain CE166 with wreU or wreG genes 
is expected to provide additional layers of evidence to determine which hypothesis is correct in 
depicting the initial step of O-antigen biosynthesis in R. etli CE3. 
 
B. Investigation of the GTase activity of WreU and its nucleotide sugar substrate 
specificity  
The wreU gene was amplified from the chromosomal DNA of R. etli CE3 and cloned into 
pET15b vector. The resultant plasmid encodes a WreU protein with an amino-terminal six-
histidine (His6) tag. The modified wreU gene (His6-wreU) was determined to be functional in vivo 
due to its ability to complement an R. etli wreU::Km mutant strain CE566 (Fig. 29). The WreU 
protein is predicted to possess one transmembrane region near its amino terminus. In accordance 
with this prediction, all His6-WreU protein expressed in E. coli located to the cell membrane 
fraction. Attempts to purify His6-WreU from the membrane fraction were not successful. Several 
other constructs were made in order to facilitate WreU purification, including placing a His6-tag 
on the carboxy-terminus of WreU, truncating the predicted amino-terminal transmembrane 
segment or constructing protein fusions. But none of them yielded WreU protein that can be 
purified. Thus, the His6-WreU-containing membrane fraction was used as WreU crude enzyme in 
the in vitro studies. 
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Figure 29. Complementation of the R. etli wreU::Km mutant strain CE566 with His6-wreU. 
Silver-stained SDS-PAGE (18% gel) of LPS samples from whole-cell lysates. Lanes: lane 1, CE3 
(wildtype); lane 2, CE566 (wreU::Km); lane 3, CE566/pLS22 (wreU::Km/His6-wreU). 
The WreU enzyme assay was carried out as a “one-pot” reaction. The putative lipid 
substrate of WreU, Und-P, was synthesized in situ from undecaprenol (Und-OH) and adenosine 
triphosphate (ATP) by a polyprenol kinase, still known by the misnomer diacylglycerol kinase 
(DGK), as described by Hartley et al. 2008 (62). The nucleotide sugar substrates tested in the 
reactions were UDP-GlcNAc (commercially available), synthesized UDP-ADHexu (in the WbpM 
reaction) and UDP-QuiNAc (in the WbpM-WreQ reaction) as described in Chapter Two. After 
removing protein contents the WbpM reaction product is pure UDP-ADHexu (Fig. 30, lane 2). 
However, due to incomplete conversion by WreQ, the WbpM-WreQ reaction product is a mixture 
of UDP-ADHexu and UDP-QuiNAc (Fig. 30, lane 4). Besides using reaction products directly, 
the UDP-sugars were also purified by TLC (Fig. 30, lane 3 and 5) and used in the WreU assay. 
All WreU assay reactions were incubated at 30 °C for 1 hour and terminated by adding 
chloroform-methanol/3:2, followed by extraction into organic and aqueous phases to separate the 
organic-soluble compounds (such as lipids) and water-soluble compounds (such as nucleotide 
sugars). The product of the WreU catalyzed reaction is expected to be an undecaprenyl 
pyrophosphate-linked sugar (Und-PP-sugar). Such a compound is expected to be in the organic 
phase after extraction. 
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Figure 30. Thymol-stained TLC plate showing the nucleotide sugar substrates for use in the 
32P-WreU enzyme assay. Lanes: lane 1, pure UDP-GlcNAc, 10 nmol; lane 2, WbpM reaction 
product, 5.2 nmol; lane 3, purified UDP-ADHexu, 2.7 nmol; lane 4, WbpM-WreQ reaction 
product, measurement of UDP-sugar content in this sample is not accurate due to the presence of 
NAD and NADH; lane 5, purified UDP-QuiNAc, 2.4 nmol. 
Radioisotope labeling was used in the WreU enzyme assay for detecting compounds of 
interest by autoradiography after separating them on TLC. Two different radioisotopes were used: 
phosphorus-32 (32P) and tritium (3H). In the 32P assay, the phosphate group of the lipid substrate 
Und-P was labeled with 32P by using ATP (γ-32P) in its synthesis. As a result, compounds 
containing the Und-32P moiety were detected; in the 3H assay, nucleotide sugar substrates were 
labeled with 3H by using UDP-[3H]GlcNAc in their synthesis. Consequently, only compounds 
with the 3H-labeled sugar moiety were detected.  
The result of 32P-WreU assay is shown in Fig. 31A. A Und-PP-sugar candidate 
(compound I) was detected in all reactions that contained UDP-ADHexu (Fig. 31A, lane 4-6). No 
compound with similar migration property was detected in reactions with pure UDP-GlcNAc as 
nucleotide-sugar substrate (Fig. 31A, lane 3). When purified UDP-QuiNAc was used as 
nucleotide substrate, a faint spot representing another Und-PP-sugar candidate (compound II) was 
observed (Fig. 31A, lane 7). Compound I and II may be Und-PP-ADHexu and Und-PP-QuiNAc, 
respectively. When quantified with phosphorimager, the compound I spots show a 30-fold higher 
intensity than the compound II spot, suggesting that the WreU catalysis is 30-fold faster with 
UDP-ADHexu as substrate than UDP-QuiNAc. Importantly, the control reactions confirmed that 
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the production of Und-PP-sugar compounds required the lipid substrate Und-P (Fig. 31A, lane 1) 
and the enzyme WreU (Fig. 31A, lane 2). 
In the 3H-WreU assay, radioactivity can be detected in the organic phase only if the 3H-
sugar moiety is transferred onto the lipid carrier. Thus, this approach provides a more direct 
observation of the WreU GTase activity. The input 3H-labeled nucleotide-sugar substrates were 
shown in Fig. 31B (top panel). 3H-labeled UDP-QuiNAc was not purified for this assay. The 
Und-PP-ADHexu candidate (compound I) was observed in a reaction that was supplied with pure 
UDP-ADHexu from the WbpM reaction (Fig. 31B, bottom panel organic phase samples, lane 3). 
The same compound was also observed in the reaction supplied with the WbpM-WreQ reaction 
mixture that contained both UDP-ADHexu and UDP-QuiNAc (lane 4). However, the Und-PP-
QuiNAc candidate (compound II) was not detected in this reaction, probably because its amount 
is below detection in our assay. Furthermore, no Und-PP-sugar candidate was observed in the 
reaction that contained pure UDP-GlcNAc (lane 2) and in the reaction that is devoid of WreU 
(lane 1). The aqueous phase samples were also analyzed by TLC (Fig. 31B, bottom panel aqueous 
phase samples). Nucleotide sugars that did not participate in the reaction were detected in lane 1 
and 2, in accordance with no WreU activity in these reactions. No UDP-ADHexu was detected in 
lane 3 and 4, consistent with the idea that UDP-ADHexu was used as the substrate by WreU. 
UDP-QuiNAc was detected in lane 4, suggesting that none or very little of it was used by WreU.  
In conclusion, the in vitro enzyme assay confirmed the GTase activity of WreU and 
revealed the nucleotide substrate specificity of WreU: UDP-ADHexu is the preferred substrate, 
UDP-QuiNAc is a much less favored substrate, and UDP-GlcNAc is not a substrate. 
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Figure 31. Analysis of the GTase activity and nucleotide sugar substrate specificity for R. 
etli WreU. (A) Autoradiograms of TLC-separated WreU reactions with radioisotope 32P-labeled 
lipid substrate Und-P. Lanes: lane 1, no lipid substrate Und-P by omitting the kinase DGK for its 
synthesis (negative control #1); lane 2, no WreU crude enzyme added to the reaction (negative 
control #2); lanes 3-7, WreU tested against different nucleotide sugar substrates as shown in the 
table above the figure. (B) Autoradiogram of TLC-separated WreU reactions with radioisotope 
3H-labeled nucleotide sugar substrates. top panel, input nucleotide sugar substrates shown by an 
autoradiogram of TLC-separated UDP-sugar compounds. Identification of each compound has 
been shown previously by NMR. bottom panel, Autoradiograms of TLC-separated compounds in 
the organic phase and aqueous phase of the WreU reaction. Lanes: lane 1, no WreU (negative 
control); lanes 2-4, WreU tested against different nucleotide sugar compounds. Compounds: I, 
Und-PP-ADHexu; II, Und-PP-QuiNAc; *, a compound derived from Und-P in the presence of E. 
coli membrane, based on its Rf value with a different TLC solvent (not shown), it is possible to 
be Und-PP (63). 
C. WreQ can reduce ADHexu to QuiNAc on the Und-PP linkage 
The foregoing result with WreU strongly supported hypothesis 2. According to that 
hypothesis, the reduction of ADHexu to QuiNAc occurs on the Und-PP linkage. To test whether 
WreQ can reduce Und-PP-ADHexu to Und-PP-QuiNAc, a WreU-WreQ coupled enzyme assay 
was carried out. 
Like the WreU assay, the WreU-WreQ coupled assay was carried out with both 32P-
labeling (Fig. 32A) and 3H-labeling (Fig. 32B). Und-PP-ADHexu (compound I) was produced in 
the WreU reaction (Fig. 32A, lane 1; Fig. 32B, lane 2), which served as the substrate of WreQ. 
Since WreQ is a reductase, a reducing agent should be required for its activity and NADH is used 
in this reaction. The activity of WreQ was tested as follows: When both WreQ and NADH were 
added to the WreU reaction mixture, compound I was completely converted to a faster-moving 
compound (compound II) (Fig. 32A, lane 4; Fig. 32B, lane 5). When NADH alone was added 
without WreQ, no conversion occurred (Fig. 32A, lane 3; Fig. 32B, lane 4); When WreQ was 
added but NADH was omitted, only a very small amount of compound II was produced (Fig. 32A, 
lane 2; Fig. 32B, lane 3). Such observations suggested that the conversion from compound I to 
compound II is a reduction reaction catalyzed by WreQ with NADH. Since WreQ was 
determined to reduce ADHexu stereospecifically in the D-gluco configuration to QuiNAc in 
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Chapter Two, compound II is very likely to be Und-PP-QuiNAc. The production of the small 
amount of compound II by WreQ in the absence of NADH may be explained by: first, there was 
contaminating NADH present in the reaction either from the crude WreU enzyme (membrane) or 
the purified WreQ enzyme; second, the amount of WreQ enzyme used in this reaction was in 
excess and the reaction was allowed to proceed much longer than needed (the evidence is 
provided in Fig. 33). Importantly, no compound II was produced if WreU was omitted (Fig. 32B, 
lane 1), which confirmed that compound II must have been converted from the WreU reaction 
product (compound I). 
 
Figure 32. Autoradiograms of TLC-separated compounds in the WreQ enzyme assay 
organic phase. (A) WreQ enzyme assay with 32P-labelling. Lanes: lane 1, WreU reaction only; 
lane 2, WreQ added to the WreU reaction; lane 3, NADH added to the WreU reaction; lane 4, 
both WreQ and NADH added to the WreU reaction. (B). WreQ enzyme assay with 3H-labelling. 
Lanes: lane 1, WreQ and NADH added to a WreU assay control reaction (no WreU); lanes 2-5, 
same setup as lanes 1-4 in panel A. Compounds: I, Und-PP-ADHexu; II, Und-PP-QuiNAc; *, 
Und-PP (see Fig. 31 legend). 
The result of the WreU-WreQ coupled assay suggested that WreQ has Und-PP-ADHexu 
reductase activity and its product is most likely Und-PP-QuiNAc. In this assay, the amount of 
WreQ enzyme added and the time allowed for the WreQ reaction were based on previous 
experiments with the UDP-linked substrate (UDP-ADHexu). To test whether the reduction of the 
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lipidated substrate (Und-PP-ADHexu) is faster and requires less WreQ enzyme, the WreU-WreQ 
coupled reactions were performed with serially diluted WreQ and the WreQ reaction was only 
allowed to proceed for one minute (instead of one hour in the experiment shown in Fig. 32). 
The result showed that the amount of Und-PP-ADHexu (compound I) converted to Und-
PP-QuiNAc (compound II) in one minute gradually increases with decreasing dilution of WreQ 
(from 10-6 to 10-2) (Fig. 33A, lane 2-6). At 10-2, the conversion was already almost completed 
(lane 6). Further increase of the amount of WreQ achieved the same result (Fig. 33, lane 7 and 8). 
The negative control (0 minute) indicated that the method to stop the reaction was effective (lane 
1). Kinetic information was estimated from the reactions with 10-3 and 10-4 diluted WreQ enzyme 
(Table 2). For comparison, the WreQ-catalyzed UDP-ADHexu reduction reactions were carried 
out and terminated at different time points (Fig. 33B). The data obtained with one-minute reaction 
time (Fig. 33B, lane 2) was used for calculation of the reaction rate (Table 2). The result 
suggested that WreQ catalyzes the reduction of ADHexu to QuiNAc orders of magnitude faster 
when it is linked to Und-PP rather than UDP. 
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Figure 33. Autoradiograph of TLC-separated WreQ enzyme assay reactions with different 
substrates. (A) WreQ catalysis with the lipidated substrate. WreQ and NADH were added to the 
WreU reaction mixture (32P) and allowed to proceed for 1 minute before terminating the reactions 
by adding chloroform-methnol/3:2 (Solvent I) and votex. Lanes: lane 1 is a 0 minute control in 
which solvent I was added before WreQ; lane 2-8 are groups that contain serial diluted WreQ, 
from 106 to 1 (undiluted). Compounds: I, Und-PP-ADHexu; II, Und-PP-QuiNAc. (B) WreQ 
catalysis with UDP-ADHexu. WreQ and NADH were added to the WbpM reaction (3H), in which 
UDP-ADHexu was produced. The WreQ catalysis was allowed for different amount of time 
before terminated by boiling. Lanes: lane 1, 0 min; lane 2, 1 min; lane 3, 5 min; lane 4, 30 min.  
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Table 2. Comparing the estimated enzymatic activities of WreQ with the two substrates, UDP-ADHexu and Und-PP-ADHexu. 
Substrate conversion was calculated from the TLC result shown in Fig. 33. The intensities of spots were measured by ImageQuantTL software for 
32P spots in Fig. 33A and by ImageJ software for 3H spots in Fig. 33B. 
Substrate 
Substrate 
Concentration [S] 
(μM) 
WreQ 
Concentration [E] 
(μM) 
Substrate 
Conversion 
(%) 
Product 
concentration [P] 
(μM) 
Reaction 
Time t (min) 
Reaction Rate 
V=[P]/t (μM/min) 
Turnover Rateγ 
V/[E] (min-1) 
Turnov
er/[S]δ 
(μM)-
1(min-1) 
UDP-
ADHexuα 500 28 13.4 66.9 1 66.9 2.39 0.0048 
Und-PP-
ADHexuβ 
0.33 0.0028 62.5 0.206 1 0.206 74 224 
0.3 0.00028 14 0.042 1 0.042 150 500 
α UDP-ADHexu was synthesized in situ from WbpM reaction with 0.5 mM UDP-GlcNAc. The conversion to UDP-ADHexu is complete. 
β Und-PP-ADHexu was synthesized in situ from DGK-WreU reaction. Its concentration was calculated from quantified radioactivity counts by phosphorimager. 
γ Differs from standard turnover number (kcat) by not using (or at least not knowing) saturating [S]. 
δ The “turnover rate” in this table underestimates the difference in catalytic efficiencies, whereas the “turnover/[S]” most likely overestimate the difference. 
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D. WreG adds the second O-antigen sugar mannose to the WreQ reaction product Und-
PP-QuiNAc 
To obtain the WreG protein for testing its enzymatic assay in vitro, the wreG gene was 
amplified from chromosomal DNA of R. etli CE3 and cloned into the pET21b vector. The 
resultant plasmid encodes a WreG protein with a carboxy-terminal His6 tag. The wreG-His6 gene 
was determined to be functional in vivo due to its ability to complement an R. etli wreG::Tn5 
mutant strain CE358 (Fig. 34). The WreG-His6 protein overexpressed in E. coli was found to 
locate in both the soluble fraction and the membrane fraction. An attempt to purify WreG-His6 
from the soluble fraction was not successful, but it can be purified from the membrane fraction 
after solubilizing membranes with Triton X-100. It is possible that WreG naturally associates 
with the membrane despite having no predicted transmembrane segment. In the enzyme assay, 
WreG was supplied either as WreG-His6-expressing E. coli membrane fraction (crude) or as 
purified protein. 
 
Figure 34. Complementation of the R. etli wreG::Tn5 mutant strain CE358 with wreG-His6. 
Silver-stained SDS-PAGE (18% gel) of LPS samples from whole-cell lysates. Lanes: lane 1, CE3 
(wildtype); lane 2, CE358 (wreG::Tn5); lane 3, CE358/pTL63 (wreG::Tn5/wreG-His6).  
To test the acceptor substrate preference of WreG, the WreG enzyme assay was coupled 
to either the WreU reaction or the WreU-WreQ coupled reaction. The two potential acceptors, 
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Und-PP-ADHexu (compound I) and Und-PP-QuiNAc (compound II), were produced in the 
WreU reaction and the WreU-WreQ coupled reaction, respectively. The predicted nucleotide 
sugar substrate of WreG is GDP-mannose and it was added to all the reactions. Results were 
analyzed by TLC with two different solvents (Fig. 35). The production of both acceptors was 
confirmed in parallel control reactions (Fig. 35, lane 2 and 3). When WreG (crude) was incubated 
with the WreU reaction, Und-PP-ADHexu (compound I) remained almost unchanged (compare 
lane 4 to lane 2 in Fig. 35). In contrast, when WreG (crude) was incubated with the WreU-WreQ 
reaction, Und-PP-QuiNAc (compound II) was almost completely converted to a slower-moving 
compound (compound III) (compare lane 5 to lane 3 in Fig. 35). Compound III is very likely to 
be Und-PP-QuiNAc-Man, a lipid-linked disaccharide resulting from the GTase activity of WreG. 
Because compound III migrated at the same place as Und-P in TLC solvent A (Fig. 35, top panel), 
another solvent (solvent B) was used, which could separate compound III from other radiolabeled 
compounds (Fig. 35, bottom panel). Purified WreG protein alone also showed GTase activity (Fig. 
35, lane 6), albeit much lower compared to the crude enzyme (compare lane 6 to lane 5), as 
revealed by partial conversion of compound II to compound III. 
The result of this assay provided strong evidence that WreG is a mannosyltransferase for 
adding the second O-antigen sugar mannose in R. etli CE3. Furthermore, WreG recognized the 
acceptor Und-PP-QuiNAc but not Und-PP-ADHexu in vitro, suggesting that the reduction of 
ADHexu to QuiNAc by WreQ should occur first. Combining the results of in vitro enzyme assays 
in this chapter, the order of reactions in vivo should be WreU→WreQ→WreG, as proposed in 
hypothesis 2. 
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Figure 35. Autoradiograms of TLC-separated WreU-WreQ-WreG coupled enzyme assay 
organic phase compounds. Dark spots represent 32P-labeled compounds. Samples from six 
reactions were analyzed by TLC with two different solvents. top panel, TLC solvent A: 2-
propanol/ammonium hydroxide/water, 6:3:1. bottom panel: TLC solvent B: 
chloroform/methanol/water, 65:25:4. Lanes: lane 1, WreU enzyme was not added; lane 2, only 
WreU reaction, no WreQ and WreG reaction; lane 3, WreU and WreQ reaction, no WreG 
reaction; lane 4, WreU reaction plus WreG enzyme, but no WreQ reaction; lane 5. WreU, WreQ 
and WreG coupled reaction, with crude WreG enzyme (membrane fraction); lane 6, WreU, WreQ 
and WreG coupled reaction, with purified WreG enzyme. Note that the WreG substrate GDP-
mannose was added to each sample. Compounds: I, Und-PP-ADHexu; Compound II, Und-PP-
QuiNAc; Compound III, Und-PP-QuiNAc-Man; *, Und-PP (see Fig. 31 legend). 
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E. R. etli wreQ::Tn5 mutant can be suppressed by introducing multiple copies of wreG gene, 
but not wreU. 
Observations of in vitro reactions described in this chapter to this point are as predicted 
by hypothesis 2 (see Discussion below). Phenotypes of the wreQ::Tn5 mutant strain (CE166) that 
fit this hypothesis have been mentioned earlier. As noted in the introduction, additional evidence 
in favor of this hypothesis may be provided by analyzing the possibility of suppression of the 
wreQ mutant phenotype when multiple copies of other genes are introduced into this mutant 
strain. The wreU and wreG genes used for this analysis were His6-wreU and wreG-His6, the same 
genes encoding protein used in the in vitro studies. The two genes were individually cloned into 
pFAJ1708 vector (51) and the resulting plasmids pLS22 (His6-wreU) and pTL63 (wreG-His6) 
were independently introduced into strain CE166, causing multicopy dosage of the wreU or the 
wreG gene. 
Suppression of the wreQ::Tn5 mutant was analyzed by observing the LPS profiles from 
the suppression strains on SDS-PAGE (Fig. 36). His6-wreU did not suppress the wreQ::Tn5 
mutant as the amount of LPS I (O-antigen-containing LPS) in the suppression strain (Fig. 36, lane 
3) was unchanged from CE166 (Fig. 36, lane 2), which was much lower than the wildtype (Fig. 
36, lane 1). In contrast, wreG-His6 suppressed the wreQ::Tn5 mutant by restoring its LPS I 
amount to near wildtype level (Fig. 36, lane 4). This result indicates that the activity of WreG was 
affected in the wreQ::Tn5 mutant while the activity of WreU was not affected. It supported 
hypothesis 2 and is consistent with the conclusion from the in vitro studies. 
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Figure 36. Suppression of R. etli wreQ::Tn5 mutant strain CE166 by introducing multiple 
copies of wreU or wreG gene. Lanes: lane 1, CE3 (R. etli wildtype strain); lane 2, CE166 
(wreQ::Tn5); lane 3, CE166/pLS22, strain CE166 harboring pLS22 plasmids expressing His6-
WreU; lane 4, CE166/pTL63, strain CE166 harboring pTL63 plasmids expressing WreG-His6. 
F.  Discussion 
The result of the in vitro enzyme assay reported in this chapter confirmed that WreU is 
the initiating GTase for O-antigen biosynthesis in R. etli CE3. Enzymes catalyzing the initiation 
reaction have been grouped into two distinct families: polyisoprenyl-phosphate N-
acetylhexosamine-1-phosphate (PNPT) and polyisoprenyl-phosphate hexose-1-phosphate (PHPT) 
transferases. PNPTs include prokaryotic and eukaryotic members while PHPTs are restricted to 
bacteria (64). The classification is mainly based on the predicted topology of the proteins and 
their substrate preference. PNPT family members are represented by WecA, which uses UDP-N-
acetyl-Hexosamine substrates. PHPT family members are represented by WbaP, which uses 
UDP-Hexose substrates (64). Based on the predicted topology and the homology to WbaPCT, 
WreU apparently belongs to the PHPT family. However, the nucleotide sugar substrate of WreU 
determined in vitro was UDP-ADHexu (a 4-keto-6-deoxy derivative of UDP-GlcNAc), which 
belongs to the UDP-N-acetyl-Hexosamine category. Thus, WreU represents a subgroup of the 
PHPT enzyme family. Other characterized enzymes that belong to this subgroup are: WbcP from 
Aeromonas hydrophila AH-3, which is a WbaP homolog and is a UDP-N-acetyl-galactosamine 
(UDP-GalNAc):Und-P GalNAc-1-P transferase (60), and PglC from Campylobacter jejuni NCTC 
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11168, which is homologous to WbaPCT and is a UDP-2,4-diacetamido-2,4,6-trideoxy-α-D-
glucopyranose (UDP-Bac):Und-P Bac-1-P transferase (65). 
The lipid substrate of WreU in the in vitro reactions is an undecaprenol lipid carrier 
(Und-P). However, the exact form of bactoprenol in R. etli CE3 is not known. A dodecaprenol 
lipid carrier (C60) has been reported to be involved in a step of core synthesis in Rhizobium 
leguminosarum 3841 and it was also present in Sinorhizhobium meliloti 1021 (66). It is possible 
that the dodecaprenol lipid carrier also exists in R. etli CE3 and is the carrier for O-antigen 
synthesis.  
Three nucleotide sugars were tested as potential substrates for WreU. They are UDP-
GlcNAc, UDP-ADHexu and UDP-QuiNAc. In the previous chapter, UDP-QuiNAc was 
synthesized in vitro from UDP-GlcNAc in a two-step reaction via an intermediate UDP-ADHexu, 
and this was the previously proposed pathway for UDP-QuiNAc biosynthesis in vivo (19). In this 
chapter, WreU was shown to prefer UDP-ADHexu as substrate. This result led to the conclusion 
that WreU is a UDP-ADHexu:Und-P ADHexu-1-P transferase and strongly suggested that the 
reduction of ADHexu to QuiNAc occurs on the Und-PP linkage in vivo instead of on the UDP 
linkage as previously proposed.  
The reduction of ADHexu to QuiNAc requires 4-reductase activity. In the previous 
chapter, WreQ exhibited 4-reductase activity in reducing UDP-ADHexu to UDP-QuiNAc in vitro. 
However, this may be an artificial reaction which only occurs in vitro with high concentrations of 
purified enzymes and substrates. In R. etli, it is possible that the WreU activity is tightly coupled 
to the 4,6-dehydratase so that all synthesized UDP-ADHexu was used by WreU for the initiating 
reaction. In this case, UDP-QuiNAc may never be synthesized in the cell because WreQ does not 
encounter UDP-ADHexu. Instead, WreQ is expected to reduce ADHexu on the Und-PP linkage. 
And indeed, WreQ was shown in this chapter to catalyze the reduction of Und-PP-ADHexu to 
Und-PP-QuiNAc.  
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In conclusion, biosynthesis of QuiNAc in R. etli CE3 is coupled to O-antigen initiation, 
as depicted in Fig. 37. In the first phase of QuiNAc biosynthesis (4,6-dehydration), the precursor 
GlcNAc is converted to ADHexu by WreV on the UDP linkage. In the second phase, the product 
UDP-ADHexu is used by WreU to initiate O-antigen biosynthesis by transferring ADHexu-1-P to 
Und-P. In the third (final) phase of QuiNAc biosynthesis (4-reduction), ADHexu is reduced to 
QuiNAc by WreQ on the Und-PP linkage. The product Und-PP-QuiNAc is considered as the first 
O-antigen intermediate and it serves as acceptor for the next O-antigen sugar. 
WreG was confirmed to be a GTase that adds the second O-antigen sugar mannose. The 
in vitro reactions showed that WreG transfers mannose from GDP-mannose to the Und-PP-
QuiNAc acceptor, but its activity was slight or undetectable with the Und-PP-ADHexu acceptor. 
On the one hand, it supported that the reduction of ADHexu to QuiNAc occurs before the 
addition of the next sugar. On the other hand, mannose should be able to be attached to ADHexu 
as this occurs in the R. etli wreQ::Tn5 mutant in which ADHexu is not reduced to QuiNAc yet 
full-length O antigen is synthesized. This activity seems to be conferred by WreG and not another 
GTase because multiple dosage of wreG gene could suppress the deficiency in O-antigen 
biosynthesis in the wreQ::Tn5 muant. It is possible that WreG could only add mannose to 
ADHexu in vivo and such a reaction requires certain conditions that could not be met in vitro. The 
WreG result in vitro gives confidence that the reactions studied in vitro in this chapter are true O-
antigen synthesis reactions in vivo. The conclusion that WreG is the GTase, that mannose is the 
sugar added, and that QuiNAc is the acceptor fits the O-antigen structure (4) and the genetics 
presented in previous studies (12). 
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Figure 37. Biosynthesis of QuiNAc is coupled to O-antigen initiation in R. etli CE3. (A) 
Reaction catalyzed by each enzyme in the QuiNAc biosynthesis pathway in R. etli CE3. (B) 
Model of QuiNAc synthesis coordinated with O-antigen initiation. The three phases of QuiNAc 
synthesis are indicated with numbers: first, UDP-GlcNAc is converted to an intermediate (UDP-
ADHexu) by the dehydratase WreV (phase #1); second, ADHexu-1-P is transferred by WreU to 
the Und-P lipid carrier (phase #2); third and last, the ADHexu moiety is reduced to QuiNAc by 
WreQ (phase #3). A potential substrate channel for UDP-ADHexu between WreV and WreU is 
indicated. Compounds: I, Und-PP-ADHexu; II, Und-PP-QuiNAc. 
The results of this chapter support the second hypothesis of the introduction. It differs 
from the first hypothesis mainly in that QuiNAc is synthesized on the Und-PP linkage rather than 
the UDP linkage. The newly identified pathway of QuiNAc biosynthesis also fits the predicted 
localization of enzymes involved in this process. The 4,6-dehydratase WreV that converts UDP-
GlcNAc to UDP-ADHexu is predicted to be an integral membrane protein and so is the initiating 
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GTase WreU that transfers ADHexu-1-P to Und-P. The two membrane-located enzymes may 
have substrate channeling which allows for a more efficient reaction (as shown in Fig. 37B). The 
WreQ protein may also be membrane associated and it may form a complex with WreV and 
WreU. This complex would allow efficient synthesis of the first O-antigen intermediate Und-PP-
QuiNAc in a confined compartment. Besides being more efficient, such an organization of 
enzymes may be protective as well. Several 4-keto-6-deoxy sugars have been reported to be 
unstable (52,57-59). UDP-ADHexu was stable enough in vitro to withstand TLC purification and 
NMR data acquisition, but it is unclear how stable will it be in the cytosol. 
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CHAPTER FOUR: GENOMIC INVESTIGATION OF QUINAC BIOSYNTHESIS 
As demonstrated in the previous chapter, biosynthesis of QuiNAc follows an 
unconventional pathway in R. etli CE3 (Fig. 37). The three enzymes involved in this process, a 
4,6-dehydratase, an initiating GTase and a 4-reductase, are encoded by genes wreV, wreU and 
wreQ, respectively in R. etli CE3. There are no biochemical investigations on QuiNAc synthesis 
in other bacteria. To gain knowledge about the prevalence of the QuiNAc synthesis pathway 
identified in R. etli CE3, a genomic approach was undertaken. Specifically, the homologs of R. 
etli WreV, WreU and WreQ were searched for in other bacterial strains using BLAST. 
 
A. WreU, WreV, WreQ are conserved in R. etli and R. leguminosarum strains 
In R. etli CE3, it is curious that wreV, wreU and wreQ are all located outside of the 28-kb 
chromosomal O-antigen genetic cluster, where most of the genes required for O-antigen 
biosynthesis are located. Even these three genes are not all located together: wreU and wreV are 
found on plasmid B with wreV downstream of wreU (20); wreQ seems to be randomly situated in 
the chromosome, bracketed by two cell wall synthesis genes (Fig. 6 (of Chapter One), Fig. 38A) 
(15,19). 
To investigate whether the presence of QuiNAc and its synthesis pathway may be 
conserved in other strains of R. etli and in strains of the closely related species R. leguminosarum, 
genomic sequence of these strains were examined for genes encoding homologs of WreV, WreU 
and WreQ, and their locations in the genome. Besides R. etli CE3, complete genomic sequence is 
available for R. etli bv. mimosae str. Mim1, R. etli CIAT 652, R. leguminosarum bv. viciae 3841, 
R. leguminosarum bv. trifolii WSM2304, R. leguminosarum bv. trifolii WSM1325, R. 
leguminosarum bv. trifolii WSM1689, and R. leguminosarum bv. trifolii CB782.  
R. etli CE3 wreU, wreV and wreQ gene homologs were found in all these strains with 
very high sequence conservation (as summarized in Table 3). Moreover, their locations in the 
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genome of these strains are conserved (Fig. 38). In all cases, the 4-reductase gene wreQ is located 
on the chromosome, while the initial GTase gene wreU and the 4,6-dehydratase gene wreV are 
found on a plasmid. 
 
Figure 38. Relative locations of wreQ, wreU and wreV genes and their homologs on the 
genomes of Rhizobium strains. (A-H) Eight R. etli or R. leguminosarum strains that have 
complete genomic sequences. wreQ, wreU and wreV gene homolog are in blue, red, and green, 
respectively. Other genes are shown in grey: oal, O-antigen ligase gene, previously designated 
orfL in R. etli CE3 (21); ddl, d-alanine--d-alanine ligase gene; murB, UDP-N-
acetylenolpyruvoylglucosamine reductase gene.
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Table 3. All Rhizobium etli and Rhizobium leguminosarum strains that have a complete genomic sequence encode R. etli CE3 WreQ, WreV 
and WreU homolog. Accession numbers are from genome sequencing projects. E-values are from BLAST alignment with genes of R. etli CE3. 
Bacterial Strain 
WreQ homolog WreV homolog WreU homolog 
Accession No. E-value Accession No. E-value Accession No. E-value 
R. etli CE3 YP_470339 0 YP_471773 0 YP_471772 2e-131 
R. etli bv. mimosae str. Mim1 YP_008365580 0 YP_008366884 0 YP_008366882 2e-139 
R. etli CIAT 652 YP_001979122 0 YP_001984979 0 YP_001984980 1e-130 
R. leguminosarum bv. viciae 3841 YP_768883 0 YP_765345 0 YP_765344 1e-121 
R. leguminosarum bv. trifolii WSM2304 YP_002282088 0 YP_002284248 0 YP_002284249 4e-123 
R. leguminosarum bv. trifolii WSM1325 YP_002976650 0 YP_002978517 0 YP_002978518 3e-124 
R. leguminosarum bv. trifolii WSM1689 AHF84840 0 AHF88737 0 AHF88738 3e-124 
R. leguminosarum bv. trifolii CB782 AHG46133 0 AHG48652 0 AHG48651 1e-129 
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The wreQ gene is inserted in a cluster of peptidoglycan biosynthesis genes, between ddl 
(D-alanine-D-alanine ligase gene) and murB (UDP-N-acetylenolpyruvoylglucosamine reductase 
gene), and wreQ is transcribed in the opposite direction. In R. leguminosarum strains, one or two 
other genes are also inserted in this locus (Fig. 38D-H). They are not functionally related to 
QuiNAc or O-antigen synthesis. 
The wreU and wreV genes are transcribed in the same direction with wreU upstream of 
wreV. The two genes are generally separated by around 200 bp with specific variations among 
strains. It is unclear whether their transcription is driven by the same promoter or wreV has its 
own promoter. A gene encoding a putative O-antigen ligase is located immediately downstream 
of wreV in all sequenced Rhizobium strains, and it is transcribed in an opposite direction. The 
mutagenesis of this gene in R. etli CE3 will be discussed in Chapter Six.  
In conclusion, the presence of wreU, wreV, wreQ homologous genes and their conserved 
location suggest that all of these Rhizobium strains may produce QuiNAc as the primer sugar of a 
polysaccharide built on the lipid carrier Und-P. The polysaccharide is mostly likely O antigen as 
in R. etli CE3 and the conserved genetic cluster containing wreU, wreV and the putative O-
antigen ligase gene seems to support that notion.  
Among R. etli and R. leguminosarum strains that have a completely sequenced genome 
except R. etli CE3, only the structure of the primary O antigen of R. leguminosarum 3841 has 
been solved (67). QuiNAc was found to be a component of that O-antigen. However, the authors 
concluded in their structural study that the QuiNAc is in the L-configuration, instead of the D-
configuration as in R. etli CE3 O-antigen. This conclusion is inconsistent with the presence of 
highly conserved gene homologs in R. leguminosarum 3841 (Table 3 and Fig. 38D), which 
predict it to make D-QuiNAc. Moreover, the L-QuiNAc biosynthetic pathway has been 
demonstrated by in vitro enzymatic studies of gene products of Vibrio cholerae serotype O37 (68). 
No gene homologs involved in L-QuiNAc biosynthesis were identified in the genome of R. 
leguminosarum 3841 in a BLAST search. This inconsistency between structural and genomic 
70 
 
 
data may be explained in several ways: first, R. leguminosarum 3841 may use a yet unknown 
pathway for synthesizing L-QuiNAc; second, the QuiNAc may be actually in D-configuration; 
and third, D-QuiNAc may be a component of a different O antigen that was not isolated in that 
structural study. 
The O-antigen structure of another R. leguminosarum strain, RBL5523, has also been 
solved (69). It is composed of →4)-α-D-Glc-(1→3)-α-D-QuiNAc-(1→ repeating units. Since 
genomic sequence is not available for this strain, the presence of wreU, wreV and wreQ homologs 
could not be verified. However, the presence of QuiNAc in the D-configuration in the O antigen 
of this strain supports our conclusion that the production of QuiNAc may be conserved in R. etli 
and R. leguminosarum strains. 
 
B. The presence of WreV and WreQ homolog in QuiNAc-containing bacteria 
QuiNAc has been identified in the O antigen or the capsular polysaccharide of bacterial 
strains that belong to other species (Table 4). Only three strains among those have a completely 
sequenced genome, they are Vibrio vulnificus M06-24, Legionella pneumophila subsp. 
pneumophila str. Philadelphia 1 and Francisella tularensis subsp. tularensis SCHU S4. Another 
QuiNAc-containing strain, Pseudomonas aeruginosa O6, while not having a complete genomic 
sequence, has been studied genetically for its B-band O-antigen synthesis and the sequence of the 
O-antigen genetic cluster is available (43).  
Without considering the transfer step, the synthesis of QuiNAc from the precursor 
GlcNAc requires the two sugar-modifying enzymes, the 4,6-dehydratase (R. etli CE3 WreV 
homolog) and the 4-reductase (R. etli CE3 WreQ homolog). The presence of the two enzymes 
would be predicted in all QuiNAc-containing bacteria unless they synthesize QuiNAc in a 
completely different way. Indeed, genes encoding the WreV and WreQ homolog were found in 
all of the four bacterial strains (Table 5). 
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Table 4. Bacterial strains that have been shown to contain D-QuiNAc in polysaccharide 
structures. 
Species Strain (Reference) 
Aeromonas salmonicida 80204-1 (70) 
Burkholderia caryophylli NCPP 2151 (71) 
Francisella tularensis Strain 15 (72), subsp. tularensis SCHU S4, subsp. holarctica LVS (73) 
Legionella pneumophila subsp. pneumophila str. Philadelphia 1 (74) 
Photorhabdus asymbiotica subsp. asymbiotica US-86 and US-87 and subsp. australis AU36, AU46, and AU92 (75) 
Pseudoalteromonas distincta KMM 638 (76) 
Pseudomonas aeruginosa O1, O4, O6, O9, O10, O12, O13, O14, O19 (45,77) 
Pseudomonas tolaasii NCPPB2192 (78) 
Rhizobium etli CE3 (4) 
Rhizobium leguminosarum RBL5523 (69) 
Vibrio cholerae H11 (79), O139 (80), O43 (81) 
Vibrio vulnificus M06-24 (82), 6353 (83) 
 
 
The presence of these two genes may be a conserved feature in all bacteria containing 
QuiNAc. Conversely, the presence of QuiNAc in bacterial strains could be predicted based on 
whether they contain the WreV and WreQ homologs. For instance, we predict that Chlorobium 
phaeobacteroides DSM 266, Herbaspirillum seropedicae SmR1, Polaromonas 
naphthalenivorans CJ2, as well as several Rhizobium and Pseudomonas strains not listed in Table 
5, produce QuiNAc that would be found if the compositions of their polysaccharides were to be 
analyzed. More examples are given in Table 6. In most of these bacterial strains, genes encoding 
the WreV and WreQ homolog are close to each other, indicating that they are functionally related.  
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Table 5. The presence of WreQ, WreV and initiating GTase homolog in QuiNAc-containing bacterial strains that have a sequenced 
genome. 
Bacterial Strain 
Initiating GTase 
WreQ homolog WreV homolog WreU homolog WbpL homolog 
Accession No.[b] E-value Accession No. E-value Accession No. E-value Accession No. E-value 
Rhizobium etli CE3 (4)[a] YP_470339 0 YP_471773 0 YP_471772 2e-131   
Pseudomonas aeruginosa O6 (84) AAF23991 2e-98 AAF23989 0   AAF23990 0 
Vibrio vulnificus M06-24 (82) YP_004189989 3e-104 YP_004189989 0 YP_004189990 2e-38   
Legionella pneumophila subsp. 
pneumophila str. Philadelphia 1 (74) YP_094797 1e-77 YP_095000 8e-122   YP_094798 1e-31 
Francisella tularensis subsp. tularensis 
SCHU S4 (73) YP_170399 9e-32 YP_170401 2e-116 YP_170400 1e-60   
[a] References following the name of bacterial strains are studies that identified QuiNAc in that strain. 
[b] Accession numbers are from genome sequencing projects, except Pseudomonas aeruginosa O6, for which the accessions were associated with Belanger, et 
al., 1999 (43). 
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Table 6. Bacterial Strains predicted to contain QuiNAc based on the presence of genes 
encoding homologs of R. etli CE3 WreV and WreQ in their genome. 
WreQ was used as the query sequence in a BLAST search against the non-redundant protein 
sequences (nr) database using the blastp algorithm. Bacterial strains selected all meet the 
following criteria: 1. encode a WreQ homolog with lower e-value than that of WbpV, 7e-91 (the 
WreQ homolog of P. aeruginosa O6); 2. have a fully-sequenced genome; 3. encode a WreV 
homolog (40 out of 41 strains contain both WreV and WreQ homolog). 
Genus Species Strain 
   Chlorobium     phaeobacteroides DSM 266 
   Colwellia     psychrerythraea 34H 
   Cycloclasticus     sp. P1 
   Gallionella     capsiferriformans ES-2 
   Geobacter 
    bemidjiensis Bem 
    sp. M21 
   Herbaspirillum     seropedicae SmR1 
   Herminiimonas     arsenicoxydans  
   Marinobacter     aquaeolei VT8 
   Methylobacillus     flagellatus KT 
   Methylomicrobium     alcaliphilum 20Z 
   Methylotenera 
    mobilis JLW8 
    versatilis 301 
   Nitrosomonas     eutropha C91 
   Pelodictyon     phaeoclathratiforme BU-1 
   Polaromonas 
    naphthalenivorans CJ2 
    sp. JS666 
   Pseudomonas 
    entomophila L48 
    fluorescens Pf0-1 
    mendocina ymp 
    monteilii SB3078 
    protegens CHA0, Pf-5 
    putida BIRD-1, GB-1, HB3267, W619 
    stutzeri DSM 10701, RCH2 
   Rhizobium 
    etli CIAT 652, bv. mimosae str. Mim1 
    leguminosarum bv. trifolii WSM1325, bv. trifolii WSM1689, bv. trifolii WSM2304, bv. viciae 3841 
   Sideroxydans     lithotrophicus ES-1 
   Thioalkalivibrio     sp. K90mix 
   Vibrio     cholerae O1 biovar El Tor str. N16961 
   Variovorax     paradoxus EPS 
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C. The presence of an initiating GTase genes next to the wreQ and (or) wreV homolog  
Due to the involvement of an initiating GTase, the QuiNAc synthesis pathway identified 
in R. etli CE3 may only apply to the cases in which QuiNAc is the first sugar transferred to the 
lipid carrier to initiate polysaccharide synthesis. The definitive evidence for a sugar being the 
initiating sugar can only be provided by in vitro biochemical studies, like in this dissertation. 
However, QuiNAc has been proposed to be the initiating sugar of the O-antigen repeating unit in 
P. aeruginosa O6 (43). It has not been specifically stated whether QuiNAc is the initiating sugar 
in other QuiNAc-containing polysaccharides. However, there are no data conflicting with the idea 
that QuiNAc is always the initiating sugar, either. 
In R. etli CE3, the O-antigen initiating GTase encoded by wreU is involved in QuiNAc 
synthesis. It transfers a 4-keto intermediate to the lipid carrier Und-P and the intermediate is 
reduced to QuiNAc on the lipid linkage. In P. aeruginosa O6, the wbpL gene encodes an 
initiating GTase that has been proposed to initiate synthesis of the repeating unit of B-band O-
antigen. QuiNAc was proposed to be the first sugar of the repeating unit (43) and WbpL was 
proposed to transfer QuiNAc-1-P from UDP-QuiNAc to the lipid carrier. However, this 
conclusion is based on genetic studies and WbpL has not been characterized biochemically. 
WbpL belongs to the PNPT family initiating GTase and its predicted topology is very different 
from WreU, which belongs to the PHPT family (Fig. 39). In the genome of P. aeruginosa O6, 
wbpL is located between the wbpV (wreQ homolog) and wbpM (wreV homolog) (Fig. 40B). To 
investigate whether an initiating GTase gene is always found next to the wreV and wreQ homolog, 
WreU of R. etli CE3 or WbpL of P. aeruginosa O6 was used as query in BLAST searches in 
QuiNAc-containing bacteria listed in Table 5. 
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Figure 39. Comparison of predicted topology between initiating GTase WbpL and WreU. 
The shaded rectangular boxes represent transmembrane (TM) segments. The numbers indicate the 
amino acid positions of the boundary of each TM domain. (A) Pseudomonas aeruginosa O6 
WbpL (Accession No.: AAF23990); (B) Rhizobium etli CE3 WreU (Accession No.: YP_471772).  
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Figure 40. Relative locations of homologous genes in R. etli CE3 and the four known 
genomes of QuiNAc-containing bacterial strains. wreV, wreQ, wreU, wbpL and their homologs 
are shown in green, blue, red, orange, respectively. 
The result of the search is also listed in Table 5. V. vulnificus M06-24 and F. tularensis 
subsp. tularensis SCHU S4 each contains a WreU homolog. L. pneumophila subsp. pneumophila 
str. Philadelphia 1 contains a WbpL homolog. The location of the initiating GTase genes were 
examined together with the wreV and wreQ homologs in these bacterial strains (Fig. 40). 
Interestingly, the three genes tend to be contiguous with the initial GTase gene in the middle (Fig. 
40B,C,E), or, in the case of R. etli CE3 (Fig. 40A) and L. pneumophila subsp. pneumophila str. 
Philadelphia 1 (Fig. 40D), two genes are contiguous while the other one is located elsewhere. In 
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strains predicted to produce QuiNAc (Table 6), it is also common for the three genes or at least 
two genes to be contiguous (data not shown). This pattern of gene location suggests that these 
genes may have related functions, that is, they are involved in QuiNAc synthesis and its transfer 
as the first sugar of a polysaccharide structure.  
 
D. Summary of the findings and speculation 
The ubiquity of a sugar ring-modifying 4,6-dehydratase (R. etli WreV homolog) and 4-
reductase (WreQ homolog) in QuiNAc-containing bacteria suggests that QuiNAc conversion 
from GlcNAc is conserved. However, there are at least two classes of initiating GTases: WreU or 
WbpL. The close linkage between an initiating GTase with the two sugar ring-modifying 
enzymes further suggests that QuiNAc may always be the initiating sugar of a polysaccharide 
built on the lipid carrier Und-P. It is highly possible that QuiNAc is synthesized in the same way 
in all QuiNAc-containing bacteria that possess WreU homologs. Although WbpL and its 
homologs have not been characterized biochemically, they might also catalyze the same reaction 
as WreU. In our model (Fig. 37B), we speculated that WreU forms a membrane complex with 
WreV. If WbpL catalyzes the same reaction as WreU, it may also interact with the WreV 
homolog (WbpM). Given the differences in their topologies, it is hard to be believe that they 
interact with the 4,6-dehydratase (WreV or WbpM) in the same manner. And this may potentially 
argue against the necessity of complex formation. 
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CHAPTER FIVE: DISCUSSION 
A. UDP-QuiNAc may be an artificial compound 
In the present study, the biosynthesis pathway of QuiNAc was determined. Unlike the 
previously proposed canonical pathway in which synthesis occurred entirely on the UDP linkage, 
QuiNAc synthesis actually begins on the UDP-linkage but finishes on the Und-PP linkage (as 
detailed in Fig. 37). According to this pathway, UDP-QuiNAc may never be synthesized in the 
cell. The reason for synthesizing QuiNAc in such a manner is unclear. One explanation is that 
UDP-QuiNAc may be toxic to the cell. Due to structural similarity to UDP-GlcNAc, UDP-
QuiNAc may affect many enzymes that are involved in UDP-GlcNAc metabolism and catalysis. 
It may inhibit the activity of these enzymes, or it may be used as substrate instead of UDP-
GlcNAc and affect a downstream event. Bacterial peptidoglycan (PGN) consists of alternating 
residues of GlcNAc and N-acetylmuramic acid (MurNAc)-pentapeptide. UDP-GlcNAc is crucial 
for PGN biosynthesis as the donor of GlcNAc and the biosynthetic precursor of UDP-MurNAc 
(85). Thus, cell wall synthesis may be one of the cellular processes affected by UDP-QuiNAc. 
The QuiNAc biosynthesis pathway determined in this study revealed an approach by which the 
cell can produce QuiNAc without the synthesis of UDP-QuiNAc. 
 
B. Potential applications of UDP-QuiNAc 
UDP-QuiNAc can be produced enzymatically in an in vitro reaction as described in 
Chapter Two. Although it may be an unnatural compound, its availability has many potential 
applications. It is a useful nucleotide sugar substrate candidate for testing the specificity of 
glycosyltransferases. In this dissertation, UDP-QuiNAc has been successfully applied in testing 
specificity of the R. etli O-antigen initiating GTase WreU. The finding that UDP-ADHexu was a 
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preferred substrate over UDP-QuiNAc was crucial in determining the pathway of QuiNAc 
biosynthesis.  
UDP-QuiNAc could also be used in testing the specificity of other initiating GTases. For 
example, WecA of E. coli has been determined in vitro to use UDP-GlcNAc as substrate and 
transfer GlcNAc-1-P to Und-P (26). UDP-QuiNAc is structurally homologous to UDP-GlcNAc, 
the only difference is at the sixth carbon of the hexose ring (-CH3 for QuiNAc, -CH2OH for 
GlcNAc). So, UDP-QuiNAc may be a substrate of WecA or it may be an inhibitor of WecA 
activity. The specific role of UDP-QuiNAc will be determined by the active site architecture of 
WecA. The crystal structure of WecA has not been solved, but if this can be achieved, UDP-
QuiNAc may help in understanding the nature of substrate specificity.  
Another GTase that can be tested with UDP-QuiNAc is MurG, which is involved in PGN 
synthesis. MurG transfers GlcNAc from UDP-GlcNAc to Und-PP-MurNAc-pentapeptide, which 
is the second step in synthesizing the Und-PP linked MurNAc-(pentapeptide)-GlcNAc alternating 
unit of PGN (13). UDP-QuiNAc might affect PGN synthesis through MurG in two ways. First, it 
may inhibit the activity of MurG thus blocking PGN synthesis. Second, UDP-QuiNAc may be 
used by MurG as a substrate and added instead of GlcNAc. However, the MurNAc-
(pentapeptide)-QuiNAc units may not be efficiently polymerized, which will also affect PGN 
synthesis. Given the essential role of PGN and the potential deleterious effects of UDP-QuiNAc 
on its synthesis, it makes sense for QuiNAc to be produced in the anchored, lipid-linked form 
instead of the soluble, UDP-linked form. 
UDP-QuiNAc may also be used for in vitro assembly of polysaccharides. If the initial 
GTase that normally uses UDP-GlcNAc can also use UDP-QuiNAc as substrate, the lipid-linked 
QuiNAc can be used as acceptor for the following steps of polysaccharide synthesis. By 
comparison with lipid-linked GlcNAc as acceptor, the importance of the primer (or first) sugar 
can be deduced. In protein N-glycosylation in eukaryotes, the first sugar of the glycan chain is 
GlcNAc (86). The initiating GTase (ALG7) that transfers GlcNAc-1-P onto the lipid carrier 
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dolichol phosphate is homologous to WecA. If this enzyme could allow substitution of GlcNAc 
with QuiNAc and the rest of glycan chain synthesis is not affected, it provides a way to label the 
glycan chain with radioisotopes. Specifically, radiolabeled (3H or 14C) UDP-QuiNAc can be used 
in the assembly of the glycan. Because UDP-QuiNAc is less likely to be used by other enzymes 
in the cell than UDP-GlcNAc, it is expected to provide a cleaner background.  
 
C. The uniqueness of the QuiNAc synthesis pathway 
To date, more than 100 sugar moieties are found in bacterial polysaccharides. Except for 
a few sugars such as glucose (Glc), galactose (Gal) and N-acetylglucosamine (GlcNAc) which are 
common components of many other structural glycans and are utilized in other housekeeping 
metabolic functions, most other sugars are synthesized as sugar nucleotides from nucleotide-
activated common sugars. Their biosynthetic pathways may comprise one to multiple steps (36). 
To our knowledge, in all biochemically characterized sugar synthesis pathways that begin with an 
NDP-sugar precursor, all synthesis steps occur on the NDP-linkage, that is, the pathway 
intermediates and the product are always NDP-linked. This makes the QuiNAc synthesis pathway 
(determined in this study) very unique, that the last step of QuiNAc synthesis (4-reduction) 
occurs on the Und-PP-linkage after the pathway intermediate is transferred from the UDP-linkage. 
Although other sugar modifications like O-methylation and O-acetylation may occur even after a 
polysaccharide is assembled (2,50), the nature of these modifications is different from the 4-
reduction step catalyzed by WreQ in QuiNAc synthesis, as they did not change the sugar ring 
itself. 
 
D. Are there other sugars synthesized in this manner?  
Although uniquely determined for QuiNAc synthesis so far, there are other sugars that 
are potentially synthesized in this manner. It is even possible that sugars shown to be synthesized 
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entirely on the NDP-linkage in vitro may actually be synthesized following a pathway resembling 
that of QuiNAc in vivo. One reason that such pathways were not identified previously is that it 
would not have been proposed, thus, the biochemical studies were biased toward not testing this 
possibility. It is worth mentioning that UDP-QuiNAc has been synthesized following the 
proposed, canonical pathway in this dissertation study, but only after conducting biochemical 
studies on other enzymes and in vivo experiments can we conclude that this is not a bonafide 
pathway in the cell. One important observation is that WreQ (the 4-reductase) catalyzes the 
reduction of UDP-ADHexu to UDP-QuiNAc very slowly. In many studies of sugar synthesis, 
kinetic information was not provided.  
Other sugars that may be synthesized in the same manner as QuiNAc are Bac 
(bacillosamine or 2,4-diamino-2,4,6-trideoxy-D-glucose), AADGal (2-acetamido-4-amino-6-
deoxygalactose) and FucNAc (N-acetyl-D-fucosamine). All three sugars have the following 
common features, which are also shared by QuiNAc: First, they have been shown or proposed to 
be the initiating sugar of a polysaccharide. In other words, they are the first sugar linked to the 
lipid carrier in the synthesis of a sugar polymer. Bac is the first sugar of the lipid-linked 
oligosaccharide (LLO) for protein N-glycosylation in Campylobacter jejuni (38). AADGal is the 
first sugar of capsular polysaccharide A (CPSA), which coats the surface of the mammalian 
symbiont Bacteroides fragilis (87). FucNAc is the first sugar of the O-antigen repeating unit in 
Pseudomonas aeruginosa O5 (61). Second, their biosyntheses all begins with the 4,6-dehydration 
of UDP-GlcNAc. Third, the 4,6-dehydratases involved are integral membrane proteins, which are 
homologous to WreV (of R. etli CE3). The biosynthesis of UDP-Bac and UDP-AADGal has been 
demonstrated in vitro with purified enzymes (38,87). The initiating GTases responsible for C. 
jejuni LLO and B. fragilis CPSA synthesis are homologous to WreU of R. etli CE3. They have 
been shown in vitro to transfer Bac-1-P or AADGal-1-P to a lipid carrier (65,87). However, the 
possibility that UDP-ADHexu is a better substrate for these initiating GTases was not 
investigated. Future studies on initiating GTases of this kind should consider that a pathway 
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intermediate may be the true substrate. The biosynthesis of FucNAc (D-configuration) has not 
been studied in vitro. The initiating GTase for its transfer in P. aeruginosa O5 is WbpLO5, a 
homolog of P. aeruginosa O6 WbpLO6. The possible FucNAc biosynthesis pathway will be 
discussed in section E below together with QuiNAc synthesis in P. aeruginosa O6. 
Sugars that are not the first residue of a polysaccharide structure may also be synthesized 
in the same manner as QuiNAc. Take QuiNAc as an example, if it is the second (or third, 
fourth…) sugar of a polysaccharide, it is linked to the non-reducing end of another sugar residue 
instead of Und-PP. Such sugars are normally transferred from NDP-sugar donors. But it is 
possible that QuiNAc is still first synthesized as Und-PP-QuiNAc following the determined 
pathway. In this case, Und-PP-QuiNAc does not serve as the stem for building a polysaccharide 
chain, but serves as the donor of QuiNAc to another growing polysaccharide. Lipid-linked sugar 
donors exist in both bacteria and eukaryotes. For example, lipid-linked galacturonic acid (GalA) 
donates the GalA residue for LPS core modification in R. leguminosarum (66). In the 
biosynthesis of lipid-linked oligosaccharides (LLOs) for protein N-glycosylation in eukaryotes, 
sugars are donated by lipid-linked sugar donors during the synthesis phase in the ER lumen (86). 
However, it should be pointed out that these lipid-linked sugar donors are different from Und-PP-
QuiNAc in two major ways. First of all, the sugar moiety of the lipid-linked sugar donors is 
transferred from an NDP-sugar. In this transfer reaction, only the sugar is transferred to the lipid 
carrier, resulting in a lipid-phosphate-sugar (lipid-P-sugar), whereas Und-PP-QuiNAc contains a 
pyrophosphate linkage; Secondly, the sugar moieties of the lipid-linked sugar donors are in their 
“final” form and are not further modified after transferred to the lipid, whereas the QuiNAc of 
Und-PP-QuiNAc is modified from ADHexu on the Und-PP linkage. Given these differences, 
whether Und-PP-QuiNAc or another lipid-PP-sugar can serve as a sugar donor requires further 
biochemical study. 
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E. Biosynthesis of QuiNAc and FucNAc in bacteria with PNPT family initiating GTases 
QuiNAc has been identified and proposed to be the first sugar transferred onto a lipid 
carrier in bacteria that contain PNPT type initiating GTase. It is unclear whether QuiNAc 
biosynthesis in these bacteria follows the same pathway as determined in R. etli CE3, which has a 
PHPT type initiating GTase (WreU). FucNAc is the C-4 epimer of QuiNAc, its synthesis is 
expect to differ from QuiNAc only by the last step, catalyzed by a 4-reductase that has a 
stereospecificity for galacto- configuration (instead of a gluco- configuration for QuiNAc). Thus, 
FucNAc biosynthesis should follow in the same manner as QuiNAc. 
P. aeruginosa serotype O5 and O6 are the best candidates for such investigation. FucNAc 
and QuiNAc have been proposed to be the initiating sugar of the repeating unit of the serotype-
specific B-band O antigen in O5 and O6, respectively (43,61). Genetic studies of O-antigen 
synthesis genes suggested that WbpL was the initiating GTase. The wbpLO5 and wbpLO6 mutants 
did not make B-band O antigen and the wbpL gene from the two serotypes can cross-complement 
each other (43). Based on these results, wbpL was postulated to have relaxed specificity, being 
able to use both UDP-QuiNAc and its C-4 epimer UDP-FucNAc as substrate.  
However, the activity of the R. etli CE3 initiating GTase WreU determined in this 
dissertation inspired another possible explanation: WbpLO5 and WbpLO6 may both use the 4-keto 
intermediate UDP-ADHexu as substrate. Thus, wbpLO5 and wbpLO6 can definitely complement 
each other. The reduction to FucNAc or QuiNAc is catalyzed by stereospecific 4-reductases on 
the Und-PP linkage. In this scenario, the P. aeruginosa initiating GTase WbpL catalyzes the same 
reaction as WreU of R. etli CE3, and the biosynthesis of FucNAc and QuiNAc in P. aeruginosa 
follows the same pathway as in R. etli CE3.  
The key to this argument is whether WbpL can use UDP-ADHexu as a substrate. One 
line of evidence suggests that a WbpL homolog may be able to use UDP-ADHexu as substrate, 
which is discussed below. The 4-keto intermediate in the QuiNAc synthesis, ADHexu, has been 
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found to naturally exist in polysaccharides of several bacterial strains (40,88-90). In Yersinia 
enterocolitica serotype O:3 wild-type strain, ADHexu was proposed to be the first sugar of the 
outer core region of LPS (equivalent to the non-repeating portion of R. etli CE3 O antigen) (40). 
Genetic studies suggested that the wbcO gene encoded the initiating GTase and proposed that it 
used UDP-ADHexu as substrate (91). WbcO belongs to the PNPT family and it was classified in 
the same subgroup as WbpL (92,93). One simple experiment to test whether WbpL can use UDP-
ADHexu as substrate is to complement a Y. enterocolitica O:3 wbcO mutant with the wbpL gene. 
However, the best way to determine the substrate specificity of WbpL (and WbcO) is to carry out 
reactions in vitro with UDP-ADHexu or UDP-QuiNAc as substrate. Another intriguing test is to 
complement an R. etli wreU mutant with wbcO (or wbpL). The result of this test may provide 
implications beyond just enzymatic activity, but regarding interaction with other enzymes. 
 
F. The possibility of a membrane-located complex formed by enzymes involved in QuiNAc 
biosynthesis  
In the model presented in Fig. 37B, R. etli CE3 WreU, WreV and WreQ proteins were 
proposed to form a membrane-bound complex. WreV belongs to a subgroup of UDP-GlcNAc 
4,6-dehydratases that are intergral membrane proteins. Because NDP-sugars are water-soluble 
compounds, it seems unnecessary for a NDP-sugar 4,6-dehydratase to be on the membrane. 
Indeed, most other 4,6-dehydratases are soluble proteins. This suggests that WreV and its 
homologs are located on the membrane for a reason. Initiating GTases, such as WreU (R. etli) and 
WbpL (P. aeruginosa) are integral membrane proteins. In R. etli CE3, WreU uses the UDP-
ADHexu (the product of WreV) as substrate for catalyzing the transfer reaction. It may directly 
acquire UDP-ADHexu from WreV through interacting with it. The 4-reductase WreQ may 
interact with WreU and reduce the ADHexu moiety after it is transferred onto the lipid carrier. 
The organization of the three enzymes into a complex may not only make QuiNAc synthesis and 
O-antigen initiation more efficient, but also may be protective. Without complex formation, 
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UDP-ADHexu synthesized by WreV may be released into the cytosol, where it can encounter the 
reductase WreQ and be reduced to UDP-QuiNAc. As discussed earlier, UDP-QuiNAc is 
potentially toxic to the cell. Also, UDP-QuiNAc is not a preferred substrate of the initiating 
GTase WreU. 
Attempts to express WreU and WreV separately as His-tagged proteins in E. coli and 
purify them were not successful. WreU could be expressed but it may aggregate on the membrane 
or form inclusion bodies, which prevent its purification. WreV expression cannot be detected in E. 
coli; possibly, the WreV protein is degraded very soon after expression. If the two proteins 
naturally form a complex in R. etli CE3, they may require co-expression for stability. Thus, 
expressing them separately in E. coli may have suffered from the absence of their partner. Co-
expression may solve the problem and improve the expression and solubilities of both proteins. 
If QuiNAc and FucNAc are produced in the same manner in P. aeruginosa as QuiNAc 
produced in R. etli CE3, then the initiating GTase WbpL, the 4,6-dehydratase WbpM and the 4-
reductase WbpV (O6) or WbpK (O5) may also form a complex. Because WbpL is structurally 
quite different from WreU, the organization of the complex may also be different from the one in 
R. etli CE3. 
 
G. The location of QuiNAc biosynthetic genes in Rhizobium species and evolutionary 
implications  
As determined in Chapter Four, all sequenced R. etli and R. leguminosarum strains 
contain homologs of R. etli CE3 wreU, wreV and wreQ gene. However, the large chromosomal 
O-antigen genetic cluster of R. etli CE3 is not conserved. O-antigen structures determined from 
Rhizobium strains vary greatly (4,67,69), even though all of them contain QuiNAc. It can be 
speculated that the ability to synthesize and attach QuiNAc was acquired separately from the rest 
of the O-antigen genes. This acquisition occured prior to the time these species diverged from 
closely related lineages. Thus, QuiNAc very likely is the common primer sugar among all R. etli 
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strains and R. leguminosarum strains. The O-antigen genetic clusters separately acquired by these 
strains accommodated this primer and resulted in varying O-antigen structures. 
The wreQ gene is separated from the wreU and wreV genes. It is unclear whether they 
were acquired separately, or whether they were acquired together and then separated. The fact 
that wreU and wreV are in close proximity makes sense because the two genes are sufficient for 
an initiating reaction, resulting in the ADHexu on the Und-PP linkage. It is possible that ADHexu 
was once a component of the O antigen or another polysaccharide. In that case, the replacement 
of it by QuiNAc was a later event following the introduction of the wreQ gene. Note that such an 
event is dependent on the degree of specificity of the succeeding enzyme in the synthesis of the O 
antigen (or other polysaccharide) if the polysaccharide remains the same otherwise. This thinking 
leads to the question of whether wreQ introduction might be coordinated with the introduction of 
other genes. 
 
H. Potential applications of the knowledge of QuiNAc biosynthesis 
Since many of the LPS monosaccharide components are rare sugars and only present in 
certain pathogenic bacterial species, these unusual sugars and the enzymes involved in their 
synthesis can be targets for novel antimicrobial drug development. An in-depth understanding of 
the biosynthetic pathways of these sugars and the mechanisms of the encoded enzymes is an 
essential first step to undertake. 
The primary role of O antigens appears to be protective and they are known as essential 
virulence determinants of pathogenic bacteria (2). So far, the sugar QuiNAc has only been 
reported in bacteria. This makes it a potential target for the treatment of bacterial infections in 
eukaryotes. Since QuiNAc is usually the primer sugar in O antigens, disrupting its biosynthesis 
may lead to the total loss of O antigen and reduced virulence. Inhibiting the enzymes required for 
QuiNAc synthesis is less likely to disrupt eukaryotic cell functions as eukaryotes do not make 
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QuiNAc and may not contain a homolog of these enzymes. One potential target is the initiating 
GTase, especially the PHPT family enzymes, as they have only been found in bacteria while 
members of the PNPT family are involved in N-glycosylation in eukaryotes (93). 
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CHAPTER SIX: METHODS 
A. Bacterial Strains and Growth Conditions 
Rhizoubium etli CE3 was derived from R. etli type strain CFN42 by a spontaneous 
mutation conferring resistance to streptomycin (94). As in all past studies of wreQ and almost all 
other studies of the LPS of R. etli CFN42, strain CE3 was the wild-type source of DNA and 
genotype for strain constructions. All R. etli strains were grown to stationary phase at 30 °C in 
TY liquid medium (0.5% tryptone (Difco Laboratories), 0.3% yeast extract (Difco), and 10 mM 
CaCl2). Unless stated otherwise, all Escherichia coli strains were grown to stationary phase at 
37 °C in Luria-Bertani (LB) liquid medium (1.0% tryptone, 0.5% yeast extract, and 0.5% NaCl). 
Agar medium contained 1.5% Bacto Agar (Difco). 
 
B. Computer Analysis of Predicted Protein Sequences 
Amino acid sequences of open reading frames (ORFs) were downloaded from National 
Center for Biotechnology Information (NCBI) database. BLAST searches were performed against 
database Non-redundant protein sequences (nr) using Blastp (protein-protein BLAST) algorithm 
(95). Alignment of predicted protein sequences was performed using Clustal Omega at the 
European Bioinformatics Institute (EBI) website (http://www.ebi.ac.uk/Tools/msa/clustalo/). 
Predicted transmembrane domains were determined by Transmembrane Helix Prediction 
(TMHMM) version 2.0 at the Center of Biological Sequence Analysis (CBS) at the Technical 
University of Denmark website (http://www.cbs.dtu.dk/services/TMHMM/).  
 
C. DNA Techniques 
R. etli genomic DNA was isolated using a GenElute Bacterial genomic DNA kit (Sigma-
Aldrich). Plasmid DNA isolation from E. coli cultures and purification from agarose gels was 
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performed using the QIAprep Spin Miniprep Kit (Qiagen) and Gel/PCR DNA Fragments 
Extraction Kit (IBI Scientific), respectively. Amounts of DNA fragments were amplified using 
the Expand High Fidelity PCR System (Roche Applied Science) with custom primers (Eurofins 
MWG Operon) containing restriction sites to facilitate cloning. Restriction enzymes and T4 DNA 
ligase were purchased from New England Biolabs (NEB). Vectors or recombinant plasmids were 
transformed into INVαF’, OmniMAX (Invitrogen) or 5-alpha (NEB) E. coli cells for cloning or 
into BL21(DE3) E. coli cells (Lucigen) for protein overexpression. DNA sequencing was 
performed by Functional Biosciences. 
 
D. Site-directed mutagenesis  
The general approach of site-directed mutagenesis is to first create a mutated copy of a 
gene on a plasmid, then transfer this plasmid into the bacterial cell to replace the wildtype copy of 
the same gene by homologous recombination, and finally the double recombinant was selected. 
The specific cases for each gene are described below. 
R. etli CE3 wreV gene— the wreV gene with about 500 bp flanking sequence on each 
side was amplified from CE3 genomic DNA by polymerase chain reaction (PCR) using primers 
wreVf-EcoRI (5'-GCCGAATTCTCCAGTCTCGACGAAC-3') and wreVr-SphI (5'-
GCCGCATGCAAGCACCAATGGTGAT-3'). The 2928 bp PCR product was digested with 
restriction enzymes EcoRI and SphI and then ligated to pEX18Tc vector (96), creating plasmid 
pTL2. pTL2 was digested with PstI, which deleted a 279 bp fragment from wreV, and the Gm 
cassette from plasmid pUCGm (97) or the Km cassette from plasmid pBSL86 (98) was inserted 
into the PstI site, creating plasmid pTL4 and pTL3, respectively.  
R. etli CE3 wreQ gene— ~1700 bp SacI-SphI fragment containing the wreQ gene was 
cut from plasmid pJBQ1 (19), then ligated to plasmid pEX18Tc, creating plasmind pTL9. pTL9 
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was digested with SalI, which deleted a 654 bp fragment from wreQ, and the Gm or Km cassette 
was inserted, creating plasmid pTL10 ad pTL11, respectively. 
R. etli CE3 O-antigen ligase gene on plasmid B (oalpB)— Because there are no 
appropriate restriction sites for generating a mutant copy of this gene, a three-piece-ligation 
approach was taken (Fig. 41). The initial 345 bp of the oalpB gene together with upstream 
sequences was amplified by PCR using primers upforwardOAL (5'-
GCGAATTCCGATGCTGGTCGAGACT-3') and upreverseOAL (5'-
GCGGTACCAGGCGGATTGACGAATA-3'). The last 16 bp of the oalpB gene together with 
downstream sequences was amplified by PCR using primers DwnForwardOAL (5'-
GCGGTACCTGTGGTTCGAAGCTGAT-3') and DwnReverseOAL (5'-
GCGCATGCTGAAGCTGGCCGAAGTT-3'). The PCR products were ligated to pCR2.1 vector 
(Invitrogen), creating plasmids pMM1 and pMM2, respectively. pMM1 was digested with EcoRI 
and KpnI to release a ~1.2 kb fragment . pMM2 was digested with KpnI and SphI to release a 
~0.9 kb fragment. The two fragments were ligated with pEX18Tc vector (three-piece-ligation), 
creating plasmid pLS35. pLS35 was digested with KpnI and the Gm cassette from plasmid 
pUCGm was ligated into this site to create plasmid pLS36. 
R. etli CE3 O-antigen ligase gene on the chromosome (oalchr)— this gene copy was also 
mutated with the three-piece-ligation method as described above. The initial 51 bp of the oalchr 
gene together with upstream sequences was amplified by PCR using primers oal(c)upfor (5'-
GCGAATTCCTTGATCCGAGTGCACC-3') and oal(c)uprev (5'-
GCGAGCTCAGGCGGATTGATGAAGA-3'). The last 26 bp of the oalpB gene together with 
downstream sequences was amplified by PCR using primers oal(c)dwnfor (5'-
GAGAGCTCGATTTGCGCCCGTCGTT-3') and oal(c)dwnrev (5'-
GAGCATGCCGCCATGGTGACGACTG-3'). The PCR products were ligated to pCR2.1 vector 
(Invitrogen), creating plasmids pLS38 and pLS39, respectively. pLS38 was digested with EcoRI 
and SacI to release a ~1000 bp fragment . pLS39 was digested with SacI and SphI to release a 
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~960 bp fragment. The two fragments were ligated with pEX18Tc vector (three-piece-ligation), 
creating plasmid pLS40. pLS40 was digested with SacI and the Gm cassette from plasmid 
pUCGm, or the Km cassette from plasmid pBSL86 was ligated into this site, creating plasmids 
pLS41 and pLS42. 
 
Figure 41. Schematic diagram showing the “three-piece-ligation” method for mutagenesis. 
The 5’ region of an ORF with upstream sequence and the 3’ region of an ORF with downstream 
sequence were separately amplified by PCR. The two PCR products and a plasmid were ligated 
via designed restriction sites (A, B and C) on the primers. The resulting plasmid carries the ORF 
with a deletion and the up- and downstream region for homologous recombination. An antibiotic 
cassette can then be inserted in the mutated ORF through restriction site B (not shown). 
R. leguminosarum bv. viciae 3841 wreU gene homolog (wreU3841)— wreU3841 was 
amplified from R. leguminosarum bv. viciae 3841 genomic DNA as a 2719 bp fragment using 
primers 3841wreUmutF (5'-GCGAATTCCTCGACCGATGACGTGA-3') and 3841wreUmutR 
(5'-GCGGTACCAACGTGCGAACATTGAC-3'). The PCR product was ligated to plasmid 
pCR2.1, creating plasmid pTL12. pTL12 was digested with EcoRI and KpnI, and the resulting 
fragment was ligated to plasmid pEX18Tc, creating plasmid pTL13. The Km cassette from 
pBSL86 was inserted in the SalI site of pTL13, creating plasmid pTL15. 
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R. leguminosarum bv. viciae 3841 wreQ gene homolog (wreQ3841)— wreQ3841 was 
amplified from 3841 genomic DNA as a 2941 bp fragment using primers 3841wreQmutF (5'-
GCTCTAGACCGTTCTGCTTGCCACC-3') and 3841wreQmutR (5'-
GCGCATGCAACTGGAAGGCCTATCG-3'). The PCR product was ligated to plasmid pCR2.1, 
creating plasmid pLS30. pLS30 was digested with XbaI and SphI to release the fragment 
containing wreQ3841, which was ligated to plasmid pEX18Tc, creating plasmid pLS32. pLS32 
was digested with PstI and the Km cassette from plasmid pBSL86 was ligated into this site, 
creating plasmid pLS33. 
Replacement of wild-type locus by homologous recombination—Plasmids carrying the 
mutated copy of genes were transferred into R. etli CE3 (or R. leguminosarum bv. viciae 3841) by 
triparental mating (99) with mobilizing-plasmid containing strain MT616 (100). Specifically, 800 
μl CE3, 200 μl MT616 and 200 μl E. coli strain harboring the mutant construct were taken from 
overnight cultures and mixed on TY agar plates. After overnight incubation at 30 °C, colonies on 
the plate were resuspended in 2 ml liquid TY media and transconjugates containing the mutant 
constructs were selected on two types of TY agar plates: (1) supplemented with 200 μg of 
streptomycin/ml, 30 μg of nalidixic acid/ml, and either 30 μg of gentamycin/ml or 30 μg of 
kanamycin/ml (depending on the antibiotic cassette inserted in the mutated gene copy), and (2) 
plates supplemented with 8 % sucrose in addition to the above antibiotics (the rationale for this 
selection is explained in (99)). Colonies from the sucrose-containing plate were streaked on the 
two kinds of plates above and TY agar plates supplemented with 1 μg of tetracycline/ml. The 
tetracycline-sensitive, sucrose-resistant colonies were saved after verification of the double 
recombination event by PCR. For selecting mutants of R. leguminosarum strains, the antibiotic 
nalidixic acid was omitted from the corresponding plates for R. etli strains. Following this method, 
plasmids pTL4 (wreV::Gm), pTL3 (wreV::Km), pTL11 (wreQ::Km), pLS36 (oalpB::Gm) or 
pLS41 (oalchr::Gm) was transferred into R. etli CE3. The resulting R. etli strains were CE568, 
CE569, CE572, CE575 and CE577, respectively. Plasmids pLS33 (wreQ3841::Km) or pTL15 
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(wreU3841::Km) was transferred into R. leguminosarum bv. viciae 3841, resulting in strain LT9 
and LT11. 
Construction of R. etli O-antigen ligase double mutant— plasmid pLS42 (oalchr::Km) 
was transferred into R. etli strain CE575 (oalpB::Gm) by triparental mating. The resulting R. etli 
strain was CE578 (oalpB::Gm, oalchr::Km). 
 
E. Complementation of mutants 
For complementation of R. etli (or R. leguminosarum) mutants, complementing DNA 
fragments were cloned into stable RK2-derived cloning vector pFAJ1708 (51), plasmid pJB21 
(derived from pFAJ1700), or plasmid pJBC1 (101). The resulting constructs were transferred into 
mutant strains by triparental mating. 
● Complementation of mutants with the corresponding wildtype genes 
Complementation of R. etli wreV mutants—the R. etli CE3 wreV gene with flanking 
sequence was amplified from CE3 genomic DNA by PCR using primers wreVf-EcoRI (5'-
GCCGAATTCTCCAGTCTCGACGAAC-3') and wreVcomp (5'-
GCCGGTACCTATCGCGTCCGTGAAC-3'). The 2969 bp PCR product was ligated to plasmid 
pCR2.1 (Invitrogen), creating plasmid pTL6. pTL6 was digested with EcoRI and KpnI and the 
resulting fragment carrying wreV was ligated to plasmid pFAJ1708 or pJB21 (J. Box, 
unpublished), creating plasmids pTL7 and pTL8, respectively. (Only the result of 
complementation with pTL7 was shown in this dissertation, but pTL8 gave the same result.) 
Complementation of R. etli wreQ mutant— plasmid pJBQ3 was used for this 
complementation. pJBQ3 is a pFAJ1708 derivative carrying a DNA fragment containing the R. 
etli wreQ gene(19). 
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● Complementation of mutants with homologous genes from other bacterial species or other 
strains of the same species 
 
Complementation of R. etli wreV mutants with P. aeruginosa wbpM— the wbpM gene 
was amplified from the pBAD-wbpM vector (provided by Dr. J. S. Lam) using primers 
pBADwbpMforward (5’-GGCATATGTTGGATAATTTGAGG-3’) and pBADwbpMreverse (5’-
TTAAGCTTTCAGGGTTCTCGCCGCC-3’). The PCR product was ligated to plasmid pCR2.1. 
This construct was digested with NdeI and HindIII, and the resulting fragment was ligated to 
plasmid pJBC1 (102), generating plasmid pTL61. 
Complementation of the R. etli wreQ mutant with P. aeruginosa wbpV— plasmid 
pFV611-26 (43) (provided by Dr. J. S. Lam, University of Guelph, Guelph, Canada) was digested 
with PstI and SacI to release a fragment containing the wbpV gene of P. aeruginosa O6. This 
fragment was inserted into two pFAJ1700 based vectors (51), generating pJB7 and pJB8, 
respectively. 
Complementation of R. leguminosarum wreQ, wreU mutants with corresponding genes of 
R. etli CE3— plasmid pJBQ3 (described above) was used for complementation of R. 
leguminosarum wreQ mutant LT9. Plasmid pKT100 was used for complementation of R. 
leguminosarum wreU mutant LT11. pKT100 is a pJB21 derivative carrying the R. etli wreU gene 
(Kristylea Ojeda, unpublished). 
● Transfer of constructs into mutant strains 
pTL7, pTL8 and pTL61 were separately transferred into CE568 and CE569; pJBQ3 was 
transferred into CE572 and LT9; pJB7 and pJB8 were transferred into CE166; pKT100 was 
transferred into LT11 by triparental mating with mobilizing plasmid-containing strain MT616. 
Strain containing these constructs were selected on TY agar plates supplemented with 200 μg of 
streptomycin/ml, 30 μg of nalidixic acid/ml (omit this antibiotic when selecting R. 
leguminosarum strains), 5 μg tetracycline/ml, 30 μg of kanamycin/ml or 30 μg of gentamycin/ml 
(depending on the recipient strain). Single colonies were purified and analyzed by SDS-PAGE. 
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F. Analysis of LPS by SDS-PAGE and LPS sugar compositions 
LPS was prepared from 0.5 ml of full-grown cultures and analyzed by SDS-PAGE with 
periodate-silver stain (21). To determine whether QuiNAc was present, LPS was extracted from 
washed bacterial pellets (from 4.0 L of culture) by the hot phenol-water method, dialyzed, treated 
with RNase A, DNase I and protease K, dialyzed again followed by lyophilization (21). For 
determination of neutral and amino sugars, LPS preparations were treated with 2 M 
trifluoroacetic acid for 2 h at 121°C. After reduction with NaBD4 and acetylation, alditol acetate 
derivatives of the LPS sugars were analyzed by gas chromatography (GC) under conditions 
described previously (21). 
 
G. Constructs for protein overexpression  
Construct for His6-WreQ overexpression— R. etli CE3 wreQ was amplified from the 
genomic DNA of R. etli CE3 using primers lpsQ-over1 (5’-
CCGGCATATGCGATGCCTCGTCACC-3’) and lpsQ-over2 (5’-
GGCCGGATCCCTATTCCACTGCAAG-3’). The ~950 bp PCR product was ligated to plasmid 
pCR2.1, creating plasmid pLS2. pLS2 was digested with NdeI and BamHI, the wreQ-containing 
fragment was inserted into the pET15b vector (Novagen), generating plasmid pLS7. The 
construct was checked by restriction digestion and nucleotide sequence determination. It encodes 
the WreQ protein with additional amino acids at the amino-terminus, 
MGSSHHHHHHSSGLVPRGSH (the His6 tag is underlined). The WreQ construct is referred to 
as His6-WreQ in this work. 
Construct for His6-WreU overexpression— R. etli CE3 wreU gene was amplified from 
the genomic DNA of R. etli CE3 using primers Lpsβ1-over1 (5’-
CCGGCATATGGGCTTGAAACGGGCG-3’) and Lpsβ1-over2 (5’-
GGCCGGATCCCTAGTGCTTTATTCC-3’). The PCR ~590 bp product was ligated into plasmid 
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pCR2.1, creating plasmid pKP2. pKP2 was digested with NdeI and BamHI and the wreU-
containing fragment was inserted into pET15b vector (Novagen), generating plasmid pLS5. The 
construct was checked by restriction digestion and nucleotide sequence determination. It encodes 
the WreU protein with additional amino acids at the amino-terminus, 
MGSSHHHHHHSSGLVPRGSH (the His6 tag is underlined). This WreU construct is referred to 
as His6-WreU in this work. 
Construct for WreG-His6 overexpression— R. etli CE3 wreG gene was amplified from 
the genomic DNA of R. etli CE3 using primers pET-wreGfor (5’- 
GCGCTAGCATGAGAGTCCTTCATTT -3’) and wreGrevXhoI (5’-
TTCTCGAGGCGGGAACCGGCCACGT-3’). The ~1130 bp PCR product was digested with 
NheI and BamHI and the wreG-containing fragment was inserted into pET21b vector (Novagen), 
generating plasmid pTL59. The construct was checked by restriction digestion and nucleotide 
sequence determination. It encodes the WreG protein with amino-terminal additional amino acids 
MAS, and carboxy-terminal additional amino acids LEHHHHHH (the His6 tag is underlined). 
This WreG construct is referred to as WreG-His6 in this work. 
Transform constructs into E. coli cells for overexpression— plasmid pLS7, pLS5 and 
pTL59 were separately transformed into E. coli BL21(DE3) cells by electroporation. 
  
H. Test the functions of the His-tagged constructs in vivo by complementation 
Complementation of the R. etli wreQ mutant with His6-wreQ— using the constructed 
plasmid pLS7 as template, the His6-wreQ gene together with the vector ribosome binding site was 
amplified with primers UQHiscomp-up (5’-GCCGAATTCATACCCACGCCGAAACAAG-3’) 
and UQHiscomp-dwn (5’-GCCGGTACCAGTTCCTCCTTTCAGCAAA-3’). The ~1390bp PCR 
product was ligated into plasmid pCR2.1, creating plasmid pLS19. pLS19 was digested with 
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EcoRI and KpnI, the His6-wreQ-containing fragment was ligated into plasmid pFAJ1708 (51), 
generating plasmid pLS31. 
Complementation of R. etli wreU mutant with His6-wreU—the His6-wreU gene together 
with the vector ribosome binding site was amplified from the constructed plasmid pLS5, with 
primers UQHiscomp-up  (5’-GCCGAATTCATACCCACGCCGAAACAAG-3’) and 
UQHiscomp-dwn (5’-GCCGGTACCAGTTCCTCCTTTCAGCAAA-3’). The ~1020 bp PCR 
product was ligated into plasmid pCR2.1, creating plasmid pLS18. pLS18 was digested with 
EcoRI and KpnI and the His6-wreU-containing fragment was ligated into plasmid pFAJ1708 (51), 
generating plasmid pLS22.  
Complementation of R. etli wreG mutant with wreG-His6—using the constructed plasmid 
pTL59 as template, the wreG-His6 gene together with the vector ribosome binding site was 
amplified with primers UQHiscomp-up (5’-GCCGAATTCATACCCACGCCGAAACAAG-3’) 
and UQHiscomp-dwn (5’-GCCGGTACCAGTTCCTCCTTTCAGCAAA-3’). This ~1570 bp 
PCR product was ligated into plasmid pCR2.1, creating plasmid pTL62. pTL62 was digested 
with XbaI and KpnI and the wreG-His6 containing fragment was ligated into plasmid pFAJ1708 
(51), generating plasmid pTL63.  
Transfer of his-tag complementation constructs into R. etli mutant strains— pLS31 (His6-
wreQ) was transferred into CE166 (wreQ::Tn5); pLS22 (His6-wreU) was transferred into CE566 
(wreU::Km); pTL63 (wreG-His6) was transferred into CE358 (wreG::Tn5) by triparental mating 
with mobilizing plasmid-containing strain MT616. Strain containing these constructs were 
selected and tested by SDS-PAGE as described above. 
 
I. Protein overexpression 
Overexpression of WbpM-His-S262— The E. coli BL21(DE3)plysS strain carrying a pET 
vector derivative encoding a soluble truncated version of the WbpM protein (residue 262-665) 
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(37) was provided by Dr. J. S. Lam. To express the WbpM-His-S262 protein, one liter LB was 
inoculated with 20 ml overnight culture of the BL21(DE3)plysS strain and grown at 37 °C. 
Protein expression was induced by addition of 0.5 mM IPTG. After 5 h induction at 37 °C, the 
cells were harvested by centrifugation at 5000 g for 15 min at 4 °C, and the pellets was stored at -
80 °C until needed. 
His6-WreQ Overexpression— BL21(DE3)/pLS7 strain grown overnight in 5 ml LB 
medium containing ampicillin (100 μg/ml) was used to inoculate a flask of one liter LB medium. 
The culture was grown at 37 °C with shaking until OD600 reached 0.6. His6-WreQ expression was 
induced by adding isopropyl β-D-1-thiogalactopyranoside (IPTG) (Gold Biotechnology) to a final 
concentration of 0.1 mM and the culture was shaken for a further 20 hours at 16 °C. Cells were 
harvested by centrifugation at 5000 g for 15 min at 4 °C, and the pellets was stored at -80 °C until 
needed. 
Overexpression of DGK, His6-WreU and WreG-His6— E. coli BL21 Gold cells carrying 
a pET vector construct encoding the Streptococcus mutans diacylglycerol kinase (DGK) with a 
carboxy-terminal His6-tag (62) was provided by Dr. Barbara Imperiali, Massachusetts Institute of 
Technology, Cambridge, MA. His6-WreU and WreG-His6 were expressed from BL21(DE3)/pLS5 
and BL21(DE3)/pTL59 strains, respectively. 
Expression of DGK, His6-WreU and WreG-His6 followed the same procedure: A flask of 
one liter LB medium containing appropriate antibiotics [ampicillin (100 μg/ml) for His6-WreU 
and WreG-His6, kanamycin (50 μg/ml) for DGK] was inoculated with a 5 ml overnight start 
culture and shake at 37 °C until an optical density between 0.6 and 0.8 was reached. The flask 
was covered with ice and chilled for 1 hour. Protein expression was induced by adding IPTG to 
the culture (final IPTG concentration: 1 mM for DGK, 0.01 mM for His6-WreU and 0.1 mM for 
WreG-His6), and the culture was shaken for a further 20 hours at 16 °C. Cells were harvested by 
centrifugation at 5000 g for 15 min at 4 °C, and the pellets was stored at -80 °C until needed. 
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J. Preparation of Membrane Fractions 
Membrane fractions were prepared from E. coli cells expressing DGK, His6-WreU and 
WreG-His6 for use as crude enzyme or for purification of membrane located proteins.  
DGK—The frozen cell pellets from 500 ml culture were thawed into 15 ml of buffer E 
(50 mM Tris, 1 mM ethylenediaminetetraacetic acid) and lysed by sonication. A low speed spin 
(6000 g, 20 min at 4 °C) removed most of the cellular debris; it was followed by high speed spin 
(65,000 g, 120 min at 4 °C) to pellet the cell membrane fraction. The pellet was preserved at -
80 °C. 
His6-WreU—The frozen cell pellets from 500 ml culture were thawed into 12 ml of 
buffer F (20 mM Tris, 300 mM NaCl, pH 8.5) and lysed by sonication. Cellular debris was 
removed by centrifugation (10,000 g for 15 min at 4 °C), and the supernatant was centrifuged at 
65,000 g for 120 min at 4 °C to pellet the cell membrane fraction. The pellet was homogenized in 
0.5 ml buffer F and aliquoted into 100 μl fractions for storage at -80 °C. 
WreG-His6—The frozen cell pellets from 500 ml culture were thawed into 12 ml of 
buffer A (20 mM sodium phosphate, 300 mM NaCl, 5 mM imidazole, pH=7.0, and 14.3 mM 2-
Mercaptoethanol) and lysed by sonication. Cellular debris was removed by centrifugation (10,000 
g for 15 min at 4 °C), and the supernatant was centrifuged at 65,000 g for 120 min at 4 °C to 
pellet the cell membrane fraction. The pellet was homogenized in 1 ml buffer A and aliquoted 
into two 0.5 ml fractions before preserved at -80 °C. 
 
K. Protein purification 
Purification of His6-WreQ— The His6-WreQ protein was purified with Ni2+ affinity 
chromatography. Specifically, the frozen cell pellets were resuspended in buffer A (20 mM 
sodium phosphate, 300 mM NaCl, 5 mM imidazole, pH=7.0, and 14.3 mM 2-Mercaptoethanol) 
and disrupted by sonication. Cellular debris was removed by centrifugation (6000 g for 20 min at 
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4 °C), and the supernatant was centrifuged at 65,000 g for 120 min at 4 °C. The supernatant was 
passed through a column containing 1 ml Ni2+-profinity IMAC resin (Bio-Rad). The column was 
washed with 10 ml buffer A followed by washing with buffer B (20 mM sodium phosphate, 300 
mM NaCl, 20 mM imidazole, pH=7.0, and 14.3 mM 2-Mercaptoethanol). His6-WreQ protein was 
eluted with buffer C (20 mM sodium phosphate, 300 mM NaCl, 300 mM imidazole, pH=7.0, and 
14.3 mM 2-Mercaptoethanol). Triton X-100 was added to the combined elution fraction to a final 
concentration of 0.1 %. Then, the elution fraction was transferred to a dialysis tubing (molecular 
weight cut off: 12-14,000 Da) and dialyzed overnight at 4 °C in 1 liter buffer containing 20 mM 
sodium phosphate, 300 mM NaCl, 14.3 mM 2-Mercaptoethanol, pH=7.0. The dialyzed protein 
sample was concentrated with Amicon Ultra-15 (nominal molecular weight limit: 10 kDa) filter 
device. The concentrated protein was fast-frozen on dry ice and preserved at -80 °C until needed. 
Typical yield of purified protein was 4.5 mg per liter of cell culture. Protein concentration was 
determined by the method of Bradford (103). 
Purification of WbpM-His-S262— Purification of WbpM-His-S262 was carried out in the 
same manner as described above for His6-WreQ, except that all the buffers (buffer A, B and C) 
do not contain 2-Mercaptoethanol. Following purification, the elution fraction was dialyzed 
against 1 L buffer (20 mM sodium phosphate, 300 mM NaCl, pH=7.0) and concentrated with 
Amicon Ultra-15 (nominal molecular weight limit: 10 kDa) filter device. Protein concentration 
was determined by the method of Bradford (103). 
Purification of DGK from membrane fractions— Cell membrane pellet was thawed and 
resuspended in 0.5 ml buffer G (20 mM sodium phosphate, 300 mM NaCl, 5 mM imidazole, pH 
8.0) and incubated with 1% CHAPS for 1 hour at 4 °C to solubilize membrane proteins. Then the 
sample was incubated with 250 μl Ni2+-profinity IMAC resin (Bio-Rad) for 30 min at 4 °C. The 
resin was placed in a 0.2 μm filter in a microcentrifuge tube for the subsequent wash and elution 
steps. The resin was washed twice with 375 μl of buffer G containing 1% CHAPS, and twice with 
375 μl of the same buffer with 45 mM imidazole. The protein was eluted three times in 200 μl of 
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the same buffer containing 300 mM imidazole. The combined elution fraction was dialyzed and 
concentrated with Amicon Ultra-0.5 (nominal molecular weight limit: 10 kDa) filter device. The 
concentrated protein was aliquoted into smaller fractions for storage at -80 °C. 
Purification of WreG-His6 from membrane fractions—Thaw one tube of 0.5 ml cell 
membrane fraction and incubated with 1% Triton X-100 for 2.5 hour at 4 °C. Then the sample 
was incubated with 200 μl Ni2+-profinity IMAC resin (Bio-Rad) for 30 min at 4 °C. The resin was 
placed in a 0.2 μm filter in a microcentrifuge tube for the subsequent wash and elution steps. The 
resin was washed twice with 250 μl of buffer A containing 0.1% Triton X-100, and twice with 
250 μl of the same buffer with 20 mM imidazole. The protein was eluted twice in 250 μl of the 
same buffer containing 300 mM imidazole. Protein sample dialysis and concentration were 
performed exactly as described for DGK above. 
 
L. Enzyme assay for WbpM and WreQ 
WbpM enzyme assay— Enzyme assays were carried out in 10-μl reactions containing 
buffer D (20 mM sodium phosphate, pH=7.0), 0.5 mM UDP-GlcNAc (Sigma), 0.029 μM 3H-
labeled UDP-GlcNAc (0.1 mCi/mmol PerkinElmer Life Sciences) and 9 µg WbpM. The reaction 
was incubated at 30 °C and allowed to proceed for 30 min for complete substrate conversion. 
WbpM-WreQ coupled enzyme assay— The WreQ catalyzed reaction was carried out by 
adding 15 μg His6-WreQ protein and 1 mM NAD(P)H to the WbpM reaction described above and 
allowed to proceed for another 4 hours. In the control reactions where one or multiple 
components were omitted, the lost volume was compensated with buffer D. 
To estimate the rate of the WreQ reaction, 10 μg His6-WreQ protein and 1 mM NAD(P)H 
were added to the WbpM reaction and the WreQ reactions were quenched at 1 min, 5 min and 30 
min. 
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Separation of sugar nucleotides by thin layer chromatography— The WbpM reaction or 
the WbpM-WreQ coupled enzyme reaction was stopped by adding an equal volume of ice-cold 
100% ethanol and proteins were removed by centrifugation (16,000 g 10 min, 4 °C) after 
overnight storage at -20 °C. The supernatant was lyophilized to dryness. The dried residues of 
radioactive reactions were dissolved in 5 µl glass distilled water. The entire volume of each 
reaction sample was spotted on an aluminum-backed precoated Silica gel 60 plate (EMD 
Chemicals) and developed in Solvent A (2-propanol/ammonium hydroxide/water, 6:3:1). Dried 
TLC plates were sprayed with EN3HANCE Autoradiography Enhancer (PerkinElmer Life 
Sciences) and exposed to film (Kodak BioMax XAR Film) for 3 days at -80 °C. 
 
M. GC-MS analysis of glycosyl residue 
To detect the glycosyl residue of the final product of the WbpM-WreQ reaction, the 
reaction was carried out in a volume of 200 μl containing buffer D, 1 mM UDP-GlcNAc, 20 µg 
WbpM, 36 µg His6-WreQ and 1 mM NADH. The lyophilized reaction mixture was treated with 1 
M hydrochloric acid for 15 min at 100 °C. After reduction with NaBD4 and acetylation, alditol 
acetate derivatives of sugars in the reaction were dissolved in dichloromethane and injected onto 
a HP-5MS (Agilent 19091S-433E) capillary column (0.25 mm inner diameter × 30 m, 0.25-µm 
film thickness) with helium as carrier gas at a flow rate of 1.0 ml/min. The GC program was 
started with an oven temperature of 50 °C, followed by an increase of 20 °C min-1 to 150 °C, then 
at 2 °C min-1 to 200 °C, then at 5 °C min-1 to 260 °C, and a hold at 260 °C for 10 min. 
  
N. Purification of nucleotide sugars by thin layer chromatography 
To purify the non-radioactive WbpM-reaction product for NMR analysis, the reaction 
was incubated at 30 °C for 1 hour with a total volume of 500 μl consisting of buffer D (20 mM 
sodium phosphate, pH=7.0), 1 mM UDP-GlcNAc and 120 µg WbpM. To purify the final product 
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of the WbpM-WreQ reaction, 450 µg His6-WreQ and 1 mM NADH was added to the WbpM 
reaction and further incubated for 4 hours. Reactions were stopped and treated as described above, 
and the dried residues after lyophilization were dissolved in a 50 µl volume in water. Of this 
solution, 24 μl (0.24 μmol) was spotted on a TLC plate (ten spots, 2 μl each) and developed in 
Solvent A as described above. One loaded lane of the TLC plate was excised from both sides of 
the TLC plate, sprayed with thymol reagent (5 mg/ml thymol in ethanol/concentrated sulfuric = 
19:1 (v/v)), and incubated in a 110 °C oven until stained spots were observed, in order to locate 
the position of the sugar nucleotide to be purified. At this position on the unstained part of the 
same TLC plate, the silica coating was scraped from the aluminum backing and the sugar 
nucleotide candidates were eluted from the silica with Solvent A. The eluates were lyophilized 
and re-dissolved in 20 μl water. The result of purification was analyzed by TLC with thymol 
staining and the concentration was measured by UV absorbance at 260 nm.  
 
O. NMR spectroscopy 
NMR experiments were performed at the static magnetic field strength of 14.1 Tesla 
(proton Larmor frequency of 600 MHz) on the Agilent VNMRS instrument equipped with the 
ColdProbe. Standard TOSCY, gCOSY, and NOESY two-dimensional pulse sequences were used 
for assignments; the pulse sequences were obtained from VNMRJ 2.0 software suite. Raw NMR 
data were processed using NMRPipe (104) and analyzed in Sparky (105). The NMR assignment 
experiments were performed at 30 °C to match conditions of the enzyme reaction directly 
monitored by NMR. In the assignment experiments 99% D2O was used as a solvent with 
presaturation of the residual water signal. The chemical shifts measured at 30 °C were referenced 
to the water resonance because its temperature dependence is well known: water chemical shift 
was calculated to be at 4.700 ppm at 30 °C (106,107). As an additional reference, we recorded the 
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chemical shift of the acetone methyl group in water at the same temperature, which was 
2.201±0.008 ppm. 
NMR samples were prepared by dissolution of lyophilized powders in 99.8% D2O 
(Cambridge Isotope Laboratories). The final concentration of UDP-QuiNAc in the Shigemi tube 
sample was 0.23 mM. The one-dimensional proton spectrum was acquired with water 
presaturation, 16,384 points and 128 transients (8 minutes of total acquisition time). All two-
dimensional experiments were acquired with 16,384 points in direct and 512 points in indirect 
dimensions. The 2D 1H-1H gCOSY was acquired in the real mode with 32 transients (5 hours). 
The 2D 1H-1H TOCSY was acquired with 16 transients (11 hours). The 2D 1H-1H NOESY was 
acquired with 16 transients in duplicate (total of 24 hours). The final concentration of the 4-keto 
intermediate was significantly lower than that of UDP-QuiNAc, which was partially compensated 
by increased acquisition time. 
 
P. In vitro WreU, WreU-WreQ coupled, and WreU-WreQ-WreG coupled enzyme assay 
Synthesis of lipid substrate Und-P— To prepare 32P-labeled Und-P for [32P]-WreU 
enzyme assay, 3 μl dimethyl sulfoxide (DMSO) and 10 μl 10% Triton X-100 were added to a 
tube containing 13 nmol of dried undecaprenol (American Radiolabeled Chemicals). The tube 
was vortexed ensure solubilization of the lipid. To the same tube, 5 μM [γ-32P]-ATP (2000 
mCi/mmol) (PerkinElmer), 1 μl of purified DGK, 10 μl 0.5 mM Tris buffer, pH 8.0, 40 mM 
MgCl2, and dH2O were added to a total volume of 100 μl. 
To prepare Und-P for [3H]-WreU enzyme assay, 0.1 mM unlabeled ATP was used 
instead, other components of the reaction were the same. The DGK reactions were incubated at 
30 °C and allowed to proceed for 1 hour before adding components for other enzymes assays.  
WreU glycosyltransferase assay— 1 μl His6-WreU-containing membrane fraction was 
added as crude WreU enzyme to the DGK reaction. In the [32P]-WreU assay, nucleotide sugar 
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substrates tested were: UDP-GlcNAc (Sigma), WbpM reaction product (contained pure UDP-
ADHexu), WbpM-WreQ reaction product (contained a mixture of UDP-ADHexu and UDP-
QuiNAc), purified UDP-ADHexu, and purified UDP-QuiNAc. The concentration of each 
nucleotide sugar substrate was 0.05 mM. 
In the [3H]-WreU assay, WreU crude enzyme and 3H-labeled nucleotide sugars were 
added to unlabeled DGK reaction. Nucleotide sugar substrates tested were UDP-[3H]GlcNAc 
(Sigma), [3H]-WbpM reaction product (contained pure UDP-[3H]ADHexu), [3H]-WbpM-WreQ 
reaction product (contained a mixture of UDP-[3H]ADHexu and UDP-[3H]QuiNAc). The 
concentration of each nucleotide sugar substrate was 0.02 mM. 
The WreU reactions were incubated at 30 °C for 1 hr, then quenched into 500 μl of 
Solvent I (chloroform-methanol/3:2) and extracted with 400 μl PSUP (chloroform-methanol-1M 
MgCl2-water/18:294:293:1) (108). The organic layers were dried with lyophilization and re-
dissolved in 20 μl Solvent I. 1 μl of each sample was spotted on an aluminum-backed precoated 
Silica gel 60 plate (EMD Chemicals) and developed in TLC Solvent A. Dried TLC plates were 
exposed to films or photostimulable phosphor (PSP) plates and viewed by autoradiogram. For the 
[3H]-WreU assay, aqueous layers of each reaction were also lyophilized, re-dissolved and the 
entire volume analyzed by TLC to view nucleotide sugars that did not participate in the reaction. 
WreU-WreQ coupled assay—To the WreU reactions, 0.1 mM NADH and 1 μl (~ 10 μg) 
WreQ enzyme were added. The WreQ reactions were allowed to proceed for 1 hour at 30 °C, 
then quenched and prepared for analysis as described above for WreU enzyme assay. 
To understand the rate of the WreQ reaction with the lipidated substrate, 0.1 mM NADH 
and 1 μl serially-diluted WreQ enzyme (10-6, 10-5, 10-4, 10-3, 10-2, 10-1 and undiluted) was added 
to [32P]-WreU reactions. The WreQ reactions were allowed for only 1 minute. To one WreU 
reaction, Solvent I was added before adding WreQ enzyme as a 0 minute control, for showing the 
effectiveness of the method of quenching the reactions. The organic phases of reaction samples 
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were analyzed by TLC expose. Radioactive (32P) spots were quantified by phosphorimager and 
used for estimating reaction kinetics. 
WreU-WreQ-WreG coupled reaction—In reactions that aimed to test the 
glycosyltransferase activity of WreG, 10 μl crude or purified WreG enzyme and 0.1 mM GDP-
mannose were added to [32P]-WreU reactions together with (or without) 10 μg WreQ and 0.1 mM 
NADH. Reactions were allowed for 1 hour after adding WreG and then quenched and prepared 
for TLC analysis. For analyzing the WreU-WreQ-WreG result, two TLC solvents were used: 
Solvent A and Solvent B (choloform/methanol/water, 65:25:4). 
 
Q. Suppression test of R. etli wreQ mutant CE166 
To test whether multicopy dosage of the wreU and/or the wreG gene could suppress the 
wreQ::Tn5 mutant CE166, pLS22 plasmid carrying the His6-wreU gene and pTL63 plasmid 
carrying the wreG-His6 gene were individually transferred into CE166 by a triparental mating 
procedure described previously (21). The LPS from the resulting strains were prepared and 
analyzed by SDS-PAGE with periodate-silver stain. 
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APPENDICES 
A. Mutants defective in the wreU and wreQ genes of Rhizobium leguminosarum 3841 
Genomic studies identified genes encoding WreU, WreV and WreQ homologs in R. 
leguminosarum 3841 (RL3841). Their functions are expected to be the same as their R. etli CE3 
orthologs, which are responsible for the coordinated QuiNAc (D-configuration) synthesis and O-
antigen initiation. However, as discussed in Chapter Four (Genomics), structural study of the O 
antigen of RL3841 identified QuiNAc in the L-configuration, but no D-QuiNAc (67). To further 
investigate this discrepancy, the roles of RL3841 wreU (wreU3841) and wreQ (wreQ3841) gene were 
investigated by site-directed mutagenesis. wreV has two almost identical copies (99% identity) in 
the genome of 3841 and their mutagenesis was not pursued. 
When analyzed on SDS-PAGE, RL3841 LPS was separated into three major bands (Fig. 
42, lane 1), a high molecular weight LPS (smooth LPS or S-LPS), a low molecular weight LPS 
(rough LPS or R-LPS) and a medium molecular weight LPS (which we call it SR-LPS here). The 
S-LPS and R-LPS of RL3841 are comparable to the LPS I and LPS II of R. etli CE3, respectively 
(Fig. 42, lane 4). Although the composition of these RL3841 LPS species is not known, it can be 
proposed that the S-LPS is composed of all three domains of LPS, whereas the R-LPS contains 
no O antigen but only the lipid A and core. The SR-LPS may contain a truncated O-antigen with 
fewer repeating units. 
In the wreU3841 mutant strain LT11 (wreU3841::Km), the O-antigen-containing S-LPS and 
SR-LPS were lost, and the amount of O-antigen-less R-LPS increases (Fig. 42, lane 2). This 
phenotype matches the R. etli wreU mutant in which LPS I is lost and the amount of LPS II 
increases. For complementation, the R. etli CE3 wreU gene was introduced into this mutant on a 
plasmid, and the LPS phenotype of this mutant was restored to wild type (Fig. 42, lane 3).  
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Figure 42. SDS-PAGE analysis of the result of wreU3841 mutagenesis and complementation 
of the mutant with R. etli CE3 wreU gene. Lanes: lane 1, R. leguminosarum 3841; lane 2, LT11 
(wreU3841::Km); lane 3, LT11/pKT100 (pKT100 is the pJB21 plasmid carrying the R. etli CE3 
wreU gene; lane 4, R. etli CE3. S-LPS and LPS I, LPS that contain lipid A, core and O-antigen; 
R-LPS and LPS II, LPS that contain lipid A and core, but no O-antigen; SR-LPS, LPS that 
contain lipid A, core, and a truncated O-antigen. 
The LPS profile of the wreQ3841 mutant strain LT9 (wreQ3841::Km) (Fig. 43A, lane 2) is 
distinct from both the wild type and the wreU3841 mutant (Fig. 43A, lane 1 and 3). The wild-type 
S-LPS band was lost in the wreQ3841 mutant, accompanied with an increased staining intensity in 
the lower molecular weight region, overlapping with the SR-LPS. This observation suggests that 
the wreQ3841 mutant may produce LPS with truncated O-antigens linked to the lipid A-core. 
Immunoblotting with antibody for RL3841 detected the S-LPS in the wild type (Fig. 43B, lane 1). 
The R-LPS in the wreU3841 mutant was not detected, indicating that the epitope for detection 
requires structural features conferred by the O-antigen. At least some of the truncated LPSs of the 
wreQ3841 mutant were detected by antibody, supporting that O-antigen is still made in this strain.  
In conclusion, mutagenesis of wreU3841 and wreQ3841 both caused mutant LPS phenotypes 
in RL3841, which confirmed their involvement in O-antigen synthesis. WreU3841 is mostly likely 
to be the initiating GTase in O-antigen synthesis, as the disruption of wreU3841 abolished O-
antigen synthesis. WreQ3841 is expected to catalyze the reduction of ADHexu to QuiNAc on the 
Und-PP linkage, as determined for WreQ of R. etli CE3. O-antigens are still made in the wreQ3841 
mutant, but with a truncated length. It can be speculated that QuiNAc is replaced by ADHexu in 
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the truncated O-antigens. It is unclear how this replacement affects the O-antigen synthesis in 
RL3841.  
The results of wreU3841 and wreQ3841 mutagenesis provide support from the genetic aspect 
that the QuiNAc in RL3841 O antigen may be actually in D-configuration. If it is in L-
configuration, the absence of WreQ activity is not expected to affect O-antigen synthesis. 
Moreover, WreU is the initiating GTase for O-antigens with D-QuiNAc as the first sugar. 
 
Figure 43. SDS-PAGE and immunoblot analysis of the LPS of R. leguminosarum 3841 
mutants. (A) Non-blotted 18% SDS-PAGE gel with LPS visualized by silver staining. (B) 
Immunoblot of a gel similar to the one shown in (A) decorated with anti-3841 antisera. Lanes: 
lane 1, R. leguminosarum 3841; lane 2, LT9 (wreQ3841::Km); lane 3, LT11 (wreU3841::Km). SDS-
PAGE and immunoblot were performed by Laurie Simonds. 
B. Mutants defective in the O-antigen ligase genes of R. etli CE3 
Until now, all ORFs within the three O-antigen genetic clusters in R. etli CE3 (shown in 
Fig. 6) have been mutated, with the exception of one gene hypothesized to encode an O-antigen 
ligase. This gene is located on plasmid B downstream of the wreV gene and is transcribed in an 
opposite direction. It had been temporarily given the name orfL in a previous study (21). When 
using the amino acid sequence of this gene product in a BLAST search against R. etli CE3, a 
homolog was found which is encoded by a chromosomal gene. The two genes are given new 
names in the present study: orfL is renamed oalpB (oal, O-antigen ligase; pB, plasmid B) and the 
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chromosome-located homolog is named oalchr (chr, chromosome). Alignment of the two gene 
products is shown in Fig. 44 and the location of the two genes in the genome is shown in Fig. 45. 
 
OalpB - M T A V T TI L S E A G K R HVRATKVNYFRQLVIAVLHPGNGSGSAL D R S N G I A V -50 
OalChr - - - - - - -- - - - - - - - ---------------------------- - - - - - - - - -0 
I 
OalpB - F L F A I LP G L S P N F N SFILLGSMLSGLYCLARARFPLNLSKSD R V V A I C M T -100
OalChr - - - - - - -- - - - - - - - ---------------------------- - - - - - - M T -2 
I 
OalpB - I Y P V V MI V S I F V N P PFSEELDWIFRLLPFFSIWLILPRMRQS P D G R L V P L -150
OalChr - I Y P L V MI A S I F I N P PYSEVGDWIFRLLPFFSIWLILPRMRQS P D G R L V P L -52 
I 
OalpB - F I L G A GL G M I V T F L FSLLQVLFLMPRAEAGTSNAALLGVIGV L F G G V A L L -200
OalChr - F I L G A GI G M I V T F L MSLLQIIFLMERAEAGTSNAALLGIIGL L F G G V A L L -102
I 
OalpB - N I Q S P KS M E Q K I A I LGYAAGLGSALLSGTRSAWLVIPVHLVI F L W Y F P K N -250
OalChr - N V Q S P KS V E Q R I A I LGYAAGLGCVLLSGTRSAWLAIPVHLVI L L W Y F R K H -152
I 
OalpB - R F H V S LR S L A I T G S VLLLGLLALGSDQVVYRVRELQDNLSSL E S T N G D I T -300
OalChr - S F H L S LR S L A I T G S LLFAGLIALGSGQIIHRIHALQENMASL E R S Q D E I T -202
I 
OalpB - S L S A R VA L Y K G A L S AIVKDPFTGYGPQNRMAAVLAEVPESLR P Q L P Y S H V -350
OalChr - S L S A R VA L Y K G A L A AISKDPLTGYGPQNRMPSVLAELPENIR P Q L P Y S H V -252
I 
OalpB - H N G F L TA G I D A G L V GIAALSLLLLTPVIGAWKKEPGPGRDLA M A L A L L L T -400
OalChr - H N G F L TA G I D A G V V GIAALSLLLLTPLIAAWKKEPGPGKDLS M A I A L L L V -302
I 
OalpB - S S Y I I TG S F G I M F N QKALDPIFAYMVALICADRGSTRYAPVV R S -444
OalChr - S S Y V I TG S F G I M F N QKALDPIFAYMVALICADRGSTRFAPVV H S -346
I 
Figure 44. Clustal alignments of the two predicted O-antigen ligases encoded in the genome 
of R. etli CE3. OalpB is encoded by the oalpB gene on plasmid B. Oalchr is encoded by the oalchr 
gene on the chromosome. Identical amino acids are highlighted. 
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Figure 45. Schematic diagram showing the location of the two O-antigen ligase genes in the 
genome of R. etli CE3. The chromosomal copy of the oal gene is located near the 28 kb O-
antigen genetic cluster, but is still separated from it by about 16 kb. The plasmid copy of oal gene 
is located immediately downstream of the wreV gene, and it is transcribed in an opposite direction. 
O-antigen ligases catalyze the transfer of the O-antigen from an Und-PP linked O-antigen 
intermediate to the lipid A-core. This reaction can be considered as the last step of O-antigen 
synthesis. Because QuiNAc is the sugar whose linkage is changed in the ligase reaction for CE3 
LPS, this step can be considered the end of the chemical journey of the QuiNAc moiety in the R. 
etli cell. Thereby the ligase reaction is logically connected to the rest of this dissertation. 
The LPS of an O-antigen ligase mutant is expected to lack O-antigen completely. To 
investigate the role of the two putative O-antigen ligase genes in O-antigen synthesis in R. etli 
CE3, the mutagenesis strategy was to create a single mutant for each gene, as well as a double 
mutant in which both genes were mutated. 
The result of mutagenesis is shown in Fig. 46. In the two single mutants, LPS I (O-
antigen containing LPS) was present (Fig. 46, lane 2 and 3), although its amount was arguably 
less than in the wild type (Fig. 46, lane 1). It is more obvious that the amount of LPS II (lipid A-
core only) increased in both single mutants. The double mutant is completely devoid of LPS I and 
its LPS II is more abundant (Fig. 46, lane 4). 
The result of mutagenesis supported that the two genes encode O-antigen ligases for R. 
etli CE3 because when both genes are mutated, no LPS I (O-antigen containing LPS) is present. 
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The result also suggests that both genes can be expressed and are functional in R. etli CE3, 
because mutating one of them did not result in the loss of LPS I. However, the ratio of LPS 
II/LPS I increased substantially in both of the single mutants, indicating that both of the two O-
antigen ligases are required for maintaining the normal LPS phenotype in the wild type. In all 
sequenced R. etli and R. leguminosarum strains, only R. etli CE3 contains two O-antigen ligase 
genes, whereas the other strains only contain the plasmid-encoded gene downstream of wreV. The 
chromosomal O-antigen ligase gene in R. etli CE3 may have resulted from a recent gene 
duplication and transposition event. The relationship between having two O-antigen ligase genes 
and the O-antigen synthesis in R. etli CE3 is unclear.  
 
Figure 46. SDS-PAGE analysis of LPS of the R. etli O-antigen ligase single mutant and 
double mutant strains. Lanes: lane 1, CE3 (wildtype); lane 2, CE575 (oalpb::Gm), plasmid B O-
antigen ligase gene mutant; lane 3, CE577 (oalchr::Gm), chromosomal O-antigen ligase gene 
mutant; lane 4, CE578 (oalpb::Gm, oalchr::Km), O-antigen ligase double mutant. This SDS-PAGE 
is performed by Laurie Simonds. 
Methods: 
Methods for site directed mutagenesis for creating RL3841 wreU3841, wreQ3841 mutants, R. 
etli CE3 O-antigen ligase (oalPB and oalchr) mutants, complementation of wreU3841, wreQ3841 
mutants with R. etli wreU and wreQ genes, SDS-PAGE and sequence alignment are described in 
Chapter Six. 
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Immunoblot analysis of LPS of RL3841 mutants— After SDS-PAGE, the mini-gel were 
electrotransferred to nitrocellulose. The dried nitrocellulose blots were immuno-stained using 
anti-3841 rabbit antisera and anti-rabbit immunoglobulin G (IgG) conjugated with alkaline 
phosphatase (Sigma). Nitrocellulose was incubated in 25 ml of TSG buffer (50 mM Tris, 0.2 M 
NaCl, 0.5% gelatin (Sigma), pH 7.4) for 10 min. This was replaced with 15 ml of TSG and 50 μl 
anti-3841 and allowed to incubate overnight on a rotating shaker. Nitrocellulose was rinsed in 
five changes of 20 ml of TSG for 10 min each, followed by the addition of a final volume of 15 
ml of TSG and 10 μl of secondary antibody and incubation on a rotating shaker for at least 3 hrs. 
Then, nitrocellulose was rinsed four times with 20 ml of TSG for five min each and developed 
with 50 mls of AMPD (100 mM 2-amino-2-methyl-1,3-proanediol (AMPD), 1 mM MgSO4, 1 
mM levamisole, pH 9.2) containing 0.1 mg/ml of nitrobluetetrazolium (NBT, Fischer Scientific) 
dissolved in water and 0.125 mg/ml of 5-bromo-4-chloro-3-indolyl phosphate (BCIP, Fischer 
Scientific) dissolved in N,N-dimethyl-formamide (DMF). 
 
